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ABSTRACT 
Igor Malashchuk 
Epigenetic Regulation of Skin Development and Postnatal Homeostasis 
The role of chromatin architectural protein Ctcf in the control of 
Keratinocyte Differentiation and Epidermal Barrier Formation 
Keywords: three dimensional genome organisation, skin, Ctcf, microarray, 
fluorescent in situ hybridization 
Epigenetic regulatory mechanisms play important roles in the control of 
lineage-specific differentiation during development. However, mechanisms 
that regulate higher-order chromatin remodelling and transcription of 
keratinocyte-specific genes that are clustered in the genome into three distinct 
loci (Keratin type I/II loci and Epidermal Differentiation Complex (EDC) during 
differentiation of the epidermis are poorly understood. By using 3D-
Fluorescent In Situ Hybridization (FISH), we determined that in the epidermal 
keratinocytes, the KtyII and EDC loci are located closely to each other in the 
nuclear compartment enriched by the nuclear speckles. However, in KtyII 
locus knockout mice, EDC locus moved away from the KtyII locus flanking 
regions and nuclear speckles towards the nuclear periphery, which is 
associated with marked changes in gene expression described previously. 
Chromatin architectural protein Ctcf has previously been implicated in the 
control of long-range enhancer-promoter contacts and inter-chromosomal 
interactions. Ctcf is broadly expressed in the skin including epidermal 
keratinocytes and hair follicles. Conditional Keratin 14-driven Ctcf ablation in 
mice results in the increase of the epidermal thickness, proliferation, 
alterations of the epidermal barrier and the development of epidermal pro-
inflammatory response. Epidermal barrier defects in Krt14CreER/Ctcf fl/fl mice 
are associated with marked changes in gene expression in the EDC and KtyII 
loci, which become topologically segregated in the nucleus upon Ctcf ablation. 
Therefore, these data suggest that Ctcf serves as critical determinant 
regulating higher-order chromatin organization in lineage-specific gene loci in 
epidermal keratinocytes, which is required for the proper control of gene 
expression, maintenance of the epidermal barrier and its function.  
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Skin has a surface area of around 2m2 in an adult human, which makes 
it the largest organ of the body (Di Meglio et al., 2011). In addition, the skin 
carries out a number of functions that are vital for the survival of the 
organism. These functions include providing a physical and biochemical 
barrier between the internal organs and the outside environment, protection 
against ultra-violet radiation and microorganisms, thermal and water 
regulation (Di Meglio et al., 2011). In addition to the skin being sensory 
perceptive, it is also elastic, stiff and has high tensile strength (Hussain et 
al., 2013). These biomechanical properties of the skin enable species to 
interact with the outside world, while at the same time being protected from 
physical trauma and other environmental stressors.  
Due to the skin being such a crucial organ in maintaining the human 
health and also important for social interactions makes the study of skin 
development as one of the key areas of biomedical research. One of the 
best models for studying mechanisms regulating skin development and 
pathobiology of skin disorders are mice (Mus musculus) because of their 
quick reproductive rate and the established techniques that enable easy 
generation of genetically-engineered mutants (Peters et al., 2007).  
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1.1. Molecular mechanisms that control development of the 
epidermis 
The biochemical and biophysical properties of epidermal barrier can 
be attributed to orchestrated expression of the epidermis-specific groups of 
genes locates in the Keratin Type I locus (mouse chromosome 11), Keratin 
Type II locus (mouse chromosome 15) and Epidermal Differentiation 
Complex (mouse Chromosome 3) (Gdula et al., 2013).   
The skin of an adult mouse is established during the different stages 
of its embryonic development. After gastrulation, the outer ectoderm cells 
eventually become epidermal progenitor cells. This happens at E9.5 
(embryonic day 9.5) when the germinative (basal) layer is established and 
these cells begin to express Keratin 5 (Fig. 1.1.a) (Koster and Roop, 2007). 
Then by E14.5, the basal cells give rise to temporary cell layer called the 
periderm and an intermediate layer. Initially, the intermediate layer, which is 
located between the basal layer and the periderm, are able to proliferate. 
However, at E15.5 they lose this ability and give rise to the spinous layer. 
The cells from the spinous layer enter a terminal differentiation program to 
produce granular layer by E16.5. Finally, the epidermal barrier (conrnified 
layer) is established by E18.5, which coincides with the loss of the periderm 
(Fig. 1.1.a) (Koster and Roop, 2007). 
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Figure 1.1. Schematic illustration of the development of mouse 
epidermis. a) Development of the epidermis during embryogenesis 
from E8.5 to E18.5. b) Development of permanent skin epidermal 
layers over time. c) Epidermal formation of wild type mice is completed 
by birth (right), however, p63-/- mice (left) are born with a single layer 
of ectodermal cells and die shortly after birth due to dehydration. d) 
Images of p63-/- and wild-type mice. Modified from (Koster and Roop, 
2007).  
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1.1.1. Molecular mechanisms responsible for establishment and 
maintenance of the basal epidermal layer 
The neuroectoderm is a single layer of cells that is found on the outer 
embryo after gastrulation. This layer gives rise to the nervous system and 
the skin epithelium. Wnt signalling pathways is the switch that regulates 
which fate the cells of the neuroectoderm will take (Fuchs, 2007). In the 
presence of Wnt signalling the ectoderm takes the epidermal fate because 
it stops responding to the fibroblast growth factors (FGFs) which in turn 
prevents downregulation of bone morphogenetic protein (BMPs) signalling 
(Fig. 1.2). When Wnt signalling is absent, the cells from the ectoderm 
progress to neurogenesis because of their response to the FGFs, which 
leads to the inhibition of BMP signalling (Fig. 1.2).   
The main characteristics of basal keratinocytes are the presence of 
keratins K5 and K14 and ability to proliferate (Byrne et al., 1994). The 
development of these features in basal cells is linked with the expression of 
transcription factor p63. Transgenic mice lacking p63 do not develop the 
basal layer and do not express K5 or K14 (Mills et al., 1999) and die soon 
after birth due to dehydration (Fig. 1.1.c,d). Different isomers of p63 protein 
are derived due to the presence of two promoters on the p63 gene. The p63 
isoforms might contain N-terminal transactivation (TA) domain or might not 
contain this domain (∆N) (Yang et al., 1998). The first isoform to be 
expressed in the epidermis is TAp63, which is able to induce the expression 
of K14 (Koster et al., 2004). Interestingly, the transcription factor (AP-2γ) 
that is implicated in regulating the expression of K14 (Byrne et al., 1994) is 
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a direct target of TAp63α. Another isoform is ∆Np63α (without TA), which is 
expressed in the epidermis after the commitment of epidermal keratinocytes 
to stratification, can also induce the expression of K14 (Romano et al., 
2007). Therefore, ∆Np63α may be involved in maintaining K14 expression 
in the basal cells postnatally.  
Epidermal fate is also associated with the expression of proteins 
required for cell adhesion, which are components of the desmosomes 
(Berika and Garrod, 2014). Perp is an adhesion protein essential for 
epithelial integrity that is expressed in the basal layer and is regulated by 
p63 (Ihrie et al., 2005). 
Also, TAp63 and ∆Np63 isoforms are required to modulate terminal 
differentiation (Koster et al., 2004; Truong et al., 2006).  Troung et el (2006) 
used primary keratinocytes under-expressing p63 to generate grafts and 
discovered that these grafts were hypoproliferative. Other data obtained 
from in vitro experiments indicated that ∆Np63α bind to the promoters of 
p21 and 14-3-3σ and reduces their expression (Westfall et al., 2003). These 
genes are upregulated during terminal differentiation. Interestingly, ∆Np63α 
is also required to regulate a signalling cascade which controls epidermal 
morphogenesis. Downregulation of p63 prevents K1 expression (Koster et 
al., 2007). ∆Np63α prevents terminal differentiation of basal cells by 
inhibiting Notch, it is also involved in a complex cross-talk with other specific 
aspects of Notch function required in the early stages of differentiation and 
K1 expression (Nguyen et al., 2006). Furthermore, a cyclin dependent 
kinase inhibitor p57Kip2 required for terminal differentiation is induced, 
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while cell-cycle progression genes, such as cyclin B2 and cdc2, are 
repressed by the ∆Np63α (Beretta et al., 2005; Testoni and Mantovani, 
2006). Most likely, the reason why ∆Np63α has two opposing functions can 
be explained by its different roles fulfilled in the early transit-amplifying and 
the late-transit amplifying basal keratinocytes (Koster et al., 2007).  
1.1.2. Molecular mechanism responsible for the formation of 
intermediate layer 
The formation of the intermediate layer is associated with the changes 
in the plane of cell division in the basal layer (Koster et al., 2007). At the 
early stages of skin development (E12.5) the formation of mitotic spindle is 
symmetric and parallel to the basement membrane (Blanpain and Fuchs, 
2009). Between E12.5 to E14.5-E17.5 (i.e., during the stratification 
process), the number of cell divisions which are asymmetric and 
perpendicular to the basement membrane rise from 0% to 70% (Blanpain 
and Fuchs, 2009). In Drosophila, it was discovered that this process is 
associated with asymmetric distribution of proteins in the cytoplasm of 
dividing cells (Roegiers and Jan, 2004). One of these proteins is Inscuteable 
which has a role in asymmetric distribution of cell fate determinants 
(Roegiers and Jan, 2004). The intermediate layer that expresses K1 and 
continues to proliferate, even if it is only for a short period of time, indicates 
that expression of K1 and cell-cycle inhibition are not linked (Koster and 
Roop, 2007). Down-regulation of ∆Np63α in basal keratinocytes prevents 
the formation of the intermediate layer and the induction of K1 expression, 
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implying that this transcription factor is critical for the initiation of epidermal 
stratification (Koster et al., 2007).  
Pathways that function downstream of ∆Np63α and contribute to the 
intermediate layer formation are Notch signalling and BMPs (Fig. 1.2). 
Other pathways that contribute to the formation of stratified epidermis are 
mitogen-activated protein kinase (MAPK), nuclear factor-κB (NF-κB), the 
AP2 family, the CCAAT/enhancer-binding protein (C/EBP) transcriptional 
regulators, interferon regulatory factor 6 (IRF6), grainyhead-like 3 (GRHL3) 
and Kruppel-like factor 4 (KLF4) (Blanpain and Fuchs, 2009).  
Notch signalling pathway includes interaction of an extracellular ligand 
interacts with the Notch receptor, resulting in the release of the NICD (Notch 
Intracellular Domain) and forming of a new complex with proteins MAML 
(mastermind-like) and RBP-J inducing the expression of the target genes 
(Artavanis-Tsakonas et al., 1999). One of the targets of Notch signalling is 
K1, the expression of which is reduced in RBP-J-/- epidermis (Blanpain et 
al., 2006). However, K1 expression is induced synergistically by both Notch 
and ∆Np63α. 
1.1.3. Molecular mechanism responsible for the formation of the 
spinous epidermal layer 
As indicated by studies of the developing mouse embryo (Koster et al., 
2007), there is a switch from a mitotic to a post-mitotic state of cells in the 
intermediate layer, which is associated with a loss of proliferation and a 
transition to spinous layer (Fig. 1.1). The transcription factor ∆Np63α is also 
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required for this process: ∆Np63α targets a gene IKKα which regulates 
epidermal stratification (Koster et al., 2007). Epidermal cells in mice lacking 
IKKα fail to develop granular and cornified layers and the K1 expressing 
cells do not lose their mitotic activity (Koster and Roop, 2007). Mouse 
models with similar phenotype include mice expressing a mutant 14-3-3σ 
(Li et al., 2005), mice without IRF6 activity (Ingraham et al., 2006), and mice 
without Ovol1. The reason why the intermediate cells in mice lacking Ovol1 
were not able to exit mitotic state was because Ovol1 directly targets c-Myc 
for transcriptional repression (Nair et al., 2006). Even though the epidermal 
phenotype of those three mouse models is similar, a direct interaction or 
relationship between them is yet to be determined.  
In the postnatal epidermis, the intermediate cell layer does not exist 
and the cells in the spinous layer are replenished directly from the basal 
layer. Notch signalling is a key regulator of the switch between proliferation 
and terminal differentiation (Koster and Roop, 2007). Notch1 causes growth 
suppression by inducing the expression of p21WAF1/Cip1 (Rangarajan et al., 
2001). Interestingly, even though ablation of Notch1 showed 
hyperproliferation in the basal layer, the spinous layer form normally 
(Rangarajan et al., 2001). Notch2 was able to compensate for the lack of 
Notch1. However, dowregulation of all Notch activity by ablating 
downstream factor RBP-J reduced the expression of spinous-layer specific 
markers, such as K1 and Involucrin (Blanpain et al., 2006). Hes1 which 
promotes terminal differentiation is targeted by Notch (Nguyen et al., 2006). 
Impaired Notch signalling can also result in the development of skin 
tumours. For example, skin squamous cell carcinomas develop when a 
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dominant-negative form of MAML1 is overexpressed (Proweller et al., 
2006). Also, spontaneous epidermal tumours develop when Notch1 is 
ablated in postnatal skin (Nicolas et al., 2003).  
1.1.4. Molecular mechanism responsible for the spinous – granular 
layer transition in the epidermis 
The process of the spinous to granular layer transition is associated 
with the down-regulation of K1 and K10 both in vitro and in vivo (Yuspa et 
al., 1989). One of the key molecules responsible for terminal differentiation 
of epidermis is the calcium (Ca2+) ion.  The extracellular concentration 
gradient of the Ca2+ is a triggers required for the formation of the spinous 
layer, granular layer and the cornified cell envelope. In vitro, if primary 
mouse keratinocytes (PMKs) are exposed to Ca2+, they initiate the terminal 
differentiation program which works similar to the terminal differentiation 
program in vivo (Yuspa et al., 1989).  Also, in PMKs, Ca2+ exposure leads 
to increase in the levels of diacyl-glycerol and phosphatidylinositol 
metabolism, which implicates phosphorylation of protein kinase C (PKC) in 
the differentiation program (Lee and Yuspa, 1991). Specifically, PKCα 
isoform is the only Ca2+ responsive serine/threonine kinase expressed in 
keratinocytes (Yang et al., 2003). Also, PKC causes down-regulation of K1 
and K10 during transition from the spinous to granular cells, and up-
regulation of the granular layer-specific markers, which are loricrin, filaggrin 
and transglutamase (Dlugosz and Yuspa, 1993). Another PKC isoform 
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PKCη is also expressed in keratinocytes, but is not responsive to Ca2+; 
however, it can also induce keratinocyte differentiation (Ohba et al., 1998).  
Interestingly, several Ca2+ binding proteins implicated in the epidermal 
stratification have been identified. For example, granular cells which lack 
Ca2+ sensing receptor have a reduced expression of loricrin and filaggrin 
(Komuves et al., 2002). However, if this receptor is overexpressed, the 
spinous and granular layers are expanded and filaggrin levels are increased 
(Turksen and Troy, 2003). In addition, the Dxl3 which may promote filaggrin 
expression is increased (Turksen and Troy, 2003). Interestingly, Dxl3 
expression is regulated by p63 and DNA-binding activity of Dxl3 is regulated 
by PKC (Park et al., 2001).  
1.1.5 Molecular mechanisms involved in the control of epidermal 
barrier formation 
Epidermal barrier formation includes the establishment of the cornified 
cell envelope during the final steps of the epidermal stratification program 
(Fig. 1.1). The transcription factors Klf4 and Grainyhead-like epithelial 
transactivator (Grhl3/Get1) have been found to play important roles in this 
process. Firstly, mutants which under-express and over-express Klf4 
display either defects in the cornified envelope structure or in accelerated 
barrier formation, respectively (Jaubert et al., 2003; Segre et al., 1999). 
Further microarray analysis on Klf4 transgenic skin identified Connexin26 to 
serve as a target, whose expression is inhibited by Klf4 (Patel et al., 2006). 
Furthermore, overexpression of Connexin26 resulted in the epidermal 
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barrier defects (Djalilian et al., 2006). Mice lacking transcription factor Grhl3 
also show defects in the barrier formation (Yu et al., 2006). Specifically, the 
defects were due to down-regulation of the genes involved in the control of 
lipid metabolism and cell adhesion (Yu et al., 2006). Furthermore, many of 
the lipid metabolism genes are also implicated in the barrier defects in mice 
lacking GATA-3 (de Guzman Strong et al., 2006). Keratinocyte specific 
deletion of Arnt also leads to the defects in the lipid metabolism (Geng et 
al., 2006). Mice ablated for Grhl3 apart from the defects in lipid metabolism 
also have abnormal expression of the tight junction genes, which are vital 
for the cell-cell adhesion and establishment of an effective epidermal barrier 
(Yu et al., 2006). The importance of the tight junctions is particularly 
emphasized by the fact that mice deficient in claudin-1 died within 1 day 
after birth due to dehydration (Furuse et al., 2002).  Furthermore, E-
cadherins are essential for regulation of the tight junctions, because 
absence of E-cadherin leads to improper localization of the key tight 
junctional proteins such as claudins (Tunggal et al., 2005).  
Epidermal differentiation complex (EDC) contains the key genes 
encoding the components of the cornified cell envelope, which are 
expressed at high levels in the epidermis. The EDC contains genes 
belonging to S100 gene family, small proline reach protein (SPRR) family, 
late cornified envelope (LCE) family, as well as Loricrin and Profillagrin (Flg) 
(Fig.1.10).  
The S100 family has 14 genes in the EDC and 13 are expressed in 
normal or diseased epidermis (Eckert et al., 2004). Loricrin contributes 
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about 70% to the mass to the cornified layer (Steinert and Marekov, 1995). 
Interestingly though, Loricrin knock-out mice are viable and the skin 
phenotype only last for the first 4-5 days after birth. It is thought that SPRRs, 
which are co-expressed with Loricrin, are able to compensate Loricrin 
functions (Koch et al., 2000). SPRRs have three sub families which are 
SPRR1/2 and 3 and have strong sequence homology with the Loricrin and 
Involucrin (Gibbs et al., 1993).  
The LCE family contains 18 genes that form the central EDC domain. 
Their structure is quite similar to the SPRR proteins, both have protein 
crosslinking functions and serve as the cornified envelope precursors 
(Marshall et al., 2001). Profillagrin contributes to cell compaction by binding 
to and condensing the keratin cytoskeleton (Sandilands et al., 2009). Loss 
of Profillagrin results in a poorly formed cornified layer, defects in epidermal 
barrier formation, and the skin is prone to the water loss (Fallon et al., 2009). 
 The cornified envelope is composed of the proteins most of which 
originate from the genes located in the Epidermal Differentiation Complex 
(EDC, mouse chromosome 3). These genes include loricirin, filaggrins, 
involucrin, small proline-rich proteins (SPRRs), S100 protein family 
members, late cornified envelope proteins (LCEs). 
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Figure 1.2. Initial signalling steps that determine the specification of 
embryonic skin. Modified from (Fuchs, 2007).  
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1.2 Hair follicle is a dynamic mini organ of the skin 
Hair is well known for being important for thermoregulation, physical 
protection, sensory perception and social interactions in mammals. 
Interestingly, just like the formation of cornified layer of the epidermis, hair 
shaft production involves terminal differentiation of keratinocytes, except, 
this process takes place in the hair follicle (HF) rather than the epidermis 
(Fig. 1.3) (Reviewed in Schneider et al.). HF formation is associated with a 
complex prototypic coordination involving ectoderm-mesoderm during 
foetal skin development (Reviewed in Fuchs, 2007; Schmidt-Ullrich and 
Paus, 2005). De novo HF formation have also been shown to happen in 
adult mouse skin (Chuong et al., 2007; Ito et al., 2007).  Most importantly, 
throughout the lifetime of a mammal HFs undergo cycle transformations 
(Paus and Foitzik, 2004; Stenn and Paus, 2001).  
The HF cycle can be characterised by three phases, which are growth 
(anagen), apoptosis-medicated regression (catagen) and quiescence 
(telogen) (Fgure 1.4) (Paus and Foitzik, 2004; Stenn and Paus, 2001). Each 
new cycle is associated with the production of new hair shaft after the old 
one has been shed (this process is called exogen) (Paus and Foitzik, 2004; 
Stenn and Paus, 2001). Mouse mutants have been very useful in 
understanding the molecular mechanisms involved in HF development and 
cycling (Nakamura et al., 2013).  
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1.2.1. Structure of the hair follicle 
 The HF consists of two parts, one of which is a permanent portion of 
the HF, while the other one undergoes remodelling during HF cycling 
(Reviewed in Botchkarev and Paus, 2003) (Fig. 1.3.b). Cycling portion of 
the HF contains secondary hair germ that is transformed into the hair bulb 
during active hair growth phase (anagen) (Fig. 1.3.b,c). In turn, the 
permanent part of the HF contains the infundibulum, the function of which 
is to provide an opening for the shaft through the skin, as well as sebaceous 
gland which duct is entered into the lower part of the infundibulum  
(Reviewed in Schneider et al., 2009).  
Below the HF infundibulum is the region called isthmus (Fig. 1.3.b) 
where the sensory nerves form a collar of fibers around the HF and the 
arrector pili muscle is attached to the connective tissue sheath surrounding 
the HF epithelium (Fig. 1.3.a) (Reviewed in Schneider et al., 2009). The 
bulge, which marks the end of the permanent region, is located at the bottom 
of the isthmus and contains HF stem cells that contribute to the regeneration 
of the cyclic portion of the HF during anagen, as well as to epidermal 
regeneration during wound healing (Fig. 1.3.b) (Reviewed in Schneider et 
al., 2009). The anagen bulb, which contains the matrix keratinocytes and 
hair pigmentation machinery, is separated from the bulge by suprabulbar 
HF epithelium. During anagen, cells of the outer root sheath and melanocyte 
progenitors originating from the corresponding precursors residing in the 
secondary hair germ, move downwards and, after reaching the hair bulb, 
generate hair matrix keratinocytes or pigment-producing melanocytes, 
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respectively. The hair matrix keratinocytes have a high proliferation capacity 
and differentiate into the hair shaft and inner root sheath keratinocytes, 
while their number and proliferative activity determines the size of the bulb 
and diameter of the hair shaft. Terminal differentiation of the hair matrix 
keratinocytes results in various types of cells of the hair shaft (medulla, 
cortex, cuticle) and the inner root sheath (Huxley, Henley and companion 
layer cells) (Fig. 1.3.c) (Reviewed in Schneider et al., 2009). Melanocytes 
residing in the hair bulb, generate a pigment, which they transport into 
differentiating hair shaft keratinocytes, thus providing pigmentation for the 
hairs.  
The dermal papilla, a mesenchymal command center of the HF, 
consists of the densely packed fibroblasts of mesenchymal origin. During 
anagen, some of these cells proliferate, and secrete growth factors and 
components of the extracellular matrix, that promote high proliferation rate 
in hair bulb keratinocytes. Furthermore, HF is enclosed by mesenchymally- 
derived connective tissue sheath, which cells are also capable of trafficking 
to the dermal papilla during anagen (Fig. 1.3.c) (Reviewed in Fuchs, 2007; 
Schneider et al., 2009; Stenn and Paus, 2001). 
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Figure 1.3. Structure of the hair follicle. (A) Haematoxylin and eosin 
staining of mouse back skin hair follicle in telogen phase. (B)  Schematic 
representation of the hair follicle and location of the stem cell compartments 
in the HF and epidermis. (C) Schematic drawing illustrating the concentric 
layers of the outer root sheath (ORS), inner root sheath (IRS) and shaft in 
the bulb. AP, arrector pili; CCL, companion cell layer; DP, dermal papilla; 
HF, hair follicle; HS, hair shaft; IFE, interfollicular epidermis; Inf, 
infundibulum; IRS, inner root sheath; Ist, Isthmus; ORS, outer root sheath, 
SC, stem cells; SG, sebaceous gland; TACs, transit-amplifying cells; CTS: 
connective tissue sheath. Modified from (Margadant et al., 2010) (A,B) and 
(Schneider et al., 2009) (C).  
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1.2.2. Hair follicle cycling  
HF cycling occurs regularly throughout the lifetime of an organism. In 
Mus musculus, HF cycling begins at about 17 days after birth after the first 
hair has been generated during morphogenesis (Fig. 1.4). From 
approximately day 17 to day 20, the HF undergoes apoptosis-driven 
involution (catagen) and enters the resting phase (telogen). The HF remains 
in telogen until the first anagen, which begins at about 3-3.5 weeks after 
birth (Fig. 1.4). It should be noted that the first telogen phase lasts for just a 
few days, while the second phase lasts up to 3 weeks (Reviewed in Fuchs, 
2007; Schneider et al., 2009; Stenn and Paus, 2001).  
The catagen phase can be described as a process during which the 
lower part of the hair follicles regresses by apoptosis of the keratinocytes 
making up the matrix, inner root sheath and outer root sheath. By the end 
of catagen, the survived hair bulb keratinocytes form secondary hair germ 
located just beneath the bulge. The stem cells in the bulge do not undergo 
apoptosis. In mice, the hair shaft from previous cycle remains in the HF even 
through new hair shaft comes out through the same hair canal. Shedding of 
the hair shaft occur through mechanical process, which mechanisms are 
still poorly understood, during the phase called exogen (Reviewed in Fuchs, 
2007; Schneider et al., 2009; Stenn and Paus, 2001).  
In mice, HF cycling tends to be synchronised among most HFs. 
However, as the animals age, the time of the telogen phase expands and 
HFs become less synchronised. In humans, on the other hand, 
synchronisation is only observed during morphogenesis and becomes 
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asynchronous after birth (Reviewed in Paus and Foitzik, 2004; Schneider et 
al., 2009).  
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Figure 1.4. Key stages of hair follicle cycle. APM: arrector pili muscle; 
DC, dermal condensate (green); DP: dermal papilla (green); HS: hair shaft 
(brown); IRS: inner root sheath (blue); MC: melanocytes; ORS: outer root 
sheath; SC: sebocytes (yellow); SG: sebaceous gland. Modified from 
(Schneider et al., 2009).  
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1.2.3. Molecular mechanisms involved in hair follicle morphogenesis 
and regeneration 
The fundamental requirement for initiation of HF morphogenesis is 
the signalling exchange between skin epithelium and mesenchyme. The 
molecules involved in this communication come from at least 5 family 
members, which include TNF, FGF, TGF-β/BMP, Hedgehog and Wnt 
families (Reviewed in Fuchs, 2007; Schmidt-Ullrich and Paus, 2005; 
Schneider et al., 2009).  
The process of the HF morphogenesis can be split into three stages 
which are induction, organogenesis and cytodifferentiation (Fig. 1.5) 
(Reviewed in Rishikaysh et al., 2014). For HF induction, Wnt ligand 
expression and secretion are required as the first step. Wnts 3/4/6 are 
essential for HF initiation, while Wnts 2/7b/10a/10b are required for further 
steps of HF development (Andl et al., 2002; Zhang et al., 2009). The function 
of Wnt pathway is to stabilise β-catenin signalling in the dermis thereby 
regulating proliferation and aggregation of dermal fibroblasts (Fig. 1.5). 
Stablization of β-catenin in the dermis is then followed by expression of β-
catenin in the epithelium of hair follicle placodes and later in the dermal 
condensate cells found in the dermal papilla (DasGupta and Fuchs, 1999; 
Fuchs, 2007; Noramly et al., 1999; Zhang et al., 2009). Lack of dermal β-
catenin is associated with reduced β-catenin activity and downregulation of 
Edar expression in the epidermis as well as with failure of fibrobrast 
aggregation (Yang et al., 2012). The Wnt/β-catenin control the expression 
of Eda and its receptor Edar, which are important for activating NF-κB 
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pathway in the HF epithelial progenitor cells (Durmowicz et al., 2002; 
Laurikkala et al., 2002; Pummila et al., 2007).  
NF-κB signalling pathway, Wnt10a/10b and Wnt inhibitor Dkk4 are 
very important for further steps of the HF placode development. The 
expression of Dkk4 is coordinated by NF-κB and LEF/TCF/β-catenin. 
Eda/Edar signalling directly activates expression of Wnt10b and NF-κB is 
important for preserving the levels of Wnt10b as well as of Wnt10a (Zhang 
et al., 2009).  
The Wnt/β-catenin and Eda/Edar induce the expression of fibroblast 
growth factor (FGF) 20 in the early stage HF placode (Huh et al., 2013). 
FGF20 is responsible for condensation of dermal fibroblasts and dermal 
papilla formation. The likely candidate receptors that could be involved in 
FGF recognition include FGFR1 and FGF2B. HF development is retarded 
following the FGFR2B deletion. During HF initiation, the receptors for 
keratinocyte growth factor (KGF) and epidermal growth factor (EGF) are 
downregulated (Chen et al., 2012; Petiot et al., 2003; Richardson et al., 
2009).  
HF organogenesis begins once keratinocytes gain immense 
proliferative ability by inhibiting Bone Morphogenetic Protein (BMP) and by 
overexpressing Sonic hedgehog (Shh) in the HF placode (Reviewed in 
Fuchs and Horsley, 2008; Millar, 2002)). The dermis produces the inhibitor 
of BMP called Noggin, which enables Lef1 to induce HF epithelia 
(Botchkarev et al., 1999).  Eda/Edar/Nf-κB activate Shh, which in turns 
activates the expression of Cyclin D1 (Andl et al., 2002; Laurikkala et al., 
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2002). Shh is not required for HF induction but is essential for down-growth 
of the HF associated with organogenesis (St-Jacques et al., 1998). Shh 
signalling is active in both the epithelium and dermal condensate. 
Interestingly, epithelial Shh is required for Noggin expression and sustained 
expression of Shh is dependent on inhibition of BMP by Noggin (Reviewed 
in Rishikaysh et al., 2014). Thus, communication between the HF epithelium 
and the mesenchyme is essential, especially for the maturation and function 
of the dermal papilla.  Other signalling components involved in driving 
Noggin expression that come from the HF epithelium include laminin-511 
and platelet-derived growth factor (PDGF), while the dermal components 
include β-catenin and PDGFα (Gao et al., 2008; Rishikaysh et al., 2014). 
When laminin-511 and β-catenin interact, they initiate the formation of 
primary dermal cilia, which is essential for the subsequent formation of the 
dermal condensate (Lehman et al., 2009). Activation of PDGFRα by PDGF 
combined with Shh signalling is required for the secretion of Noggin by the 
dermal cells. The proliferation of HF epithelium occurs as a result of 
activation of Ras/MAPK pathway by transcription factor called Snail, which 
itself is activated by TGF-β2 signalling. Absence of TGF-β2 or Snail stalls 
HF morphogenesis (Jamora et al., 2005).  
Cytodifferentiation is the final stage of HF development which 
involves the production of all the remaining structural components of the HF 
(Fig. 1.5). The inner root sheath formation is regulated by the transcription 
factors Gata3 and Cutl (Ellis et al., 2001; Kurek et al., 2007). The hair shaft 
forms as a result of BMP signalling activity in both epithelium and 
mesenchyme, while transcription factors Msx2, FoxN1 and Hoxc13 regulate 
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hair-specific differentiation of hair matrix cells (Godwin and Capecchi, 1998; 
Johns et al., 2005; Kulessa et al., 2000; Ma et al., 2003; Tkatchenko et al., 
2001). FoxN1 has an additional role in controlling the pigment transfer from 
melanocytes to keratinocytes (Mecklenburg et al., 2001; Weiner et al., 
2007). The expression of FoxN1 gene occurs as a result of cooperation 
between the Wnt5a and Notch signalling pathway.  
BMP6, which reduces cell migration, and Sostdc1 (inhibitor of BMP6) 
are also important for regulation of hair growth (Clavel et al., 2012). Both 
genes are transcriptional targets of Sox2. Sox2-mediated up- or down-
regulation of the BMP6 and Sostdc1 are important for the control of hair 
growth (Clavel et al., 2012). BMP and BMPRIA have also been implicated 
in the HF cytodifferentiation, specifically in the establishment of progenitor 
cells of the inner root sheath and hair shaft through the cross-talk between 
HF epithelium and dermal papilla (Botchkarev et al., 1999; Kobielak et al., 
2003). The BMPRIA is the only known BMP receptor located in the HF 
epithelium (Kobielak et al., 2003). Its activation by BMP4 induces terminal 
differentiation of the inner root sheath progenitor cells through the 
expression of GATA3 (Xu et al., 1999). Furthermore, hair shaft 
development, which involves Wnt signalling, is mediated by BMPRIA. In this 
BMPRIA activity is important for maintaining Lef1 levels and stabilization of 
β-catenin (Kobielak et al., 2003). Lef-1 also induces the expression of potent 
hair shaft differentiation factors Dlx3 and Hoxc13 (Hwang et al., 2008). 
Currently, it is believed that epithelial BMP4 activates a number of 
transcriptional factors including Msx1, which are able to induce BMP4 
expression in the dermis (Saadi et al., 2013).  
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HF regeneration (telogen to anagen transition) involves the cross-
talk between the BMP and Wnt signalling pathways. The communication 
between the stem cells located in the HF and the dermal papilla is essential 
at the beginning of this process. TGF-β2 activates Smad2/3 pathway in the 
stem cells and expression of Tmeff1 is induced (Oshimori and Fuchs, 2012). 
Tmeff1 is able to promote telogen to anagen transition by lowering the 
threshold of BMP (Oshimori and Fuchs, 2012). The first cells to be activated 
during regeneration are secondary hair germ cells (Greco et al., 2009). The 
newly formed dermal papilla provides the signals for the undifferentiated 
bulge stem cells, which are located along the outer root sheath, to 
proliferate. This cells become transient amplifying matrix cells, which being 
in contact with dermal papilla differentiate into inner root sheath and hair 
shaft (Reviewed in Rishikaysh et al., 2014). 
The process of anagen-catagen transition involves massive 
apoptosis in the cycling portion of the hair follicle, which is regulated by a 
number of pro-apoptotic signalling pathways (TNF, neurotrophin receptor), 
as well as by FGF receptor signalling (Reviewed in Stenn and Paus, 2001). 
During catagen, selected epithelial cells in the cycling portion of the HF 
survive and form the secondary hair germ, while the dermal papilla cells do 
not undergo apoptosis and form a ball of condensed cells beneath the 
secondary hair germ. During telogen, the communication between the 
epithelial and mesenchymal cells of the hair follicle appear to be minimal, 
while signalling exchange is activated during new hair cycle (Botchkarev 
and Kishimoto, 2003).  
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Figure 1.5. Hair follicle morphogenesis. Explained in text (Adapted from 
Rishikaysh et al., 2014) 
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1.3. Epigenetic regulatory mechanisms that control 
development of the epidermis 
The term ‘epigenetics’ was first proposed by Conrad Waddington who 
defined it as “the branch of biology which studies the causal interactions 
between genes and their products which bring the phenotype into being” 
(Waddington, 1968). Initially, this was a broad terminology which included 
all molecular pathways that regulate the expression of the genotype into a 
particular phenotype (Dupont et al., 2009). However, after tremendous 
amount of progress in epigenetic research it now has a narrower definition 
which is “the study of changes in gene function that are mitotically and/or 
meiotically heritable and that do not entail a change in the DNA sequence” 
(Wu and Morris, 2001).  
It is fascinating that all the cells of an organism have identical DNA 
content but the observed phenotypes of the different tissues and organs are 
completely different. These differences are due to different gene expression 
programs that are established in tissue-specific progenitor cells and their 
differentiating daughter cells (Fessing, 2014). DNA-binding transcription 
factors, which are able to induce or repress gene expression by recognising 
the specific sequence of DNA bases in the promoter regions, can contribute 
towards determining the pattern of gene expression (Bird, 2002). However, 
during development, the transcription potentials of the genome can be 
restricted in a manner that cannot only be explained by DNA transcription 
factors themselves (Bird, 2002).  
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During terminal keratinocyte differentiation in the epidermis, nucleus 
shows dramatic changes in the morphology and transit from an active state 
seen in the basal, spinous and granular layers to inactive state  becoming a 
part of the keratinized cornified layer and epidermal barrier (Botchkarev et 
al., 2012). There are a number of epigenetic mechanisms that can affect the 
development of an animal and are able to fulfil the criterion of heritability. 
Epigenetic mechanisms most often associated with regulating gene 
expression programs are DNA modifications via DNA methylation and 
hydroxy-methylation, post-translational histone modifications, Polycomb-
dependent gene silencing, higher order chromatin remodelling and three-
dimensional (3D) genome organisation (Ho and Crabtree, 2010). Their 
mechanisms of action and roles in epidermal development are explained in 
more details below.  
1.3.1. DNA methylation and hydroxy-methylation 
DNA methylation and hydroxy-methylation are part of DNA 
modification processes that control gene expression. DNA methylation is 
carried out by DNA methyltransferases (DNMTs), which are capable of 
transferring a methyl group from a methyl donor, S-adenosyl-L-methionine 
(SAM), to the 5-position of cytosine in CpG dinucleotide, thereby producing 
methylcytosine (5mCpG) (Jin and Robertson, 2013). Hydroxy-methylation 
is carried out by ten-eleven-translocation (TETs) enzymes, which work by 
oxidising the 5 position of methylcytosine, thereby producing 
hydroxymethylcytosine (5hmCpG) (Branco et al., 2012). The role of 
hydroxy-methylation is not fully understood, however, it is believed that 
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5hmC is an intermediate mark which results in the loss of 5mC and/or it 
might be an epigenetic mark that recruits unique chromatin or transcription 
modifying enzymes (Branco et al., 2012).  
DNA methyltransferases (DNMTs) 
The family of DNMTs includes four members which are DNMT1, 
DNMT3A, DNMT3B and DNMT3L. The enzymatic activity of DNMT3L is 
absent, however, it does stimulate catalytic activity in culture by physically 
associating with DNMT3A and DNMT3B and is required for embryonic survival 
past E8.5 (Gopalakrishnan et al., 2008; Kareta et al., 2006). DNMT1 is 
crucial for maintaining DNA methylation in daughter cells after replication 
(Lei et al., 1996; Li et al., 1992), while DNMT3A and DNMT3B are essential 
for de novo DNA methylation (Okano et al., 1999; Okano et al., 1998). 
Knock-out mice for the DNMTs die at E9.5 (DNMT1-/-) (Li et al., 1992), 
E14.5-18.5 (DNMT3B-/-) and 4 weeks (DNMT3A-/-) (Okano et al., 1999). 
Transcription silencing by DNA methylation of imprinted genes, 
transposable elements and genes located on inactive X chromosome, is 
essential to maintain chromosome stability (Jin and Robertson, 2013). Also, 
dynamic expression of DNMTs is observed during embryonic development 
and differentiation (Watanabe et al., 2002). For example, the promoter of 
transcription factor Oct4, which is required to maintain undifferentiated 
state, is hypomethylated in mouse embryonic stem (ES) cells and is 
hypermethylated in trophoblast stem cells (Hattori et al., 2004).  
DNA methylation also plays an important role in skin development. In 
particular, levels of DNMT1 are enriched in the basal keratinocytes (Sen et 
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al., 2010). Depletion of DNMT1 leads to premature differentiation and exit 
from the progenitor function, which results in tissue loss (Sen et al., 2010). 
UHRF1 is a protein that targets DNMT1 to hemi-methylated DNA after 
replication, and is also required to prevent premature differentiation. During 
differentiation de-methylation of the promoters belonging to large number of 
epidermal differentiation genes occurs (Sen et al., 2010).  For this process, 
Gadd45 (A11, A12 and A13) promoting DNA de-methylation is required 
(Sen et al., 2010). Therefore, dynamic DNA methylation pattern are required 
for both progenitor and somatic cell maintenance in the epidermal tissue. 
Recently, it has been shown using human samples that aging of the 
epidermis is associated with methylation changes which are localised to the 
promoter and enhancer regions which were linked to modified 
transcriptional activity (Raddatz et al., 2013).   
Even though methylation of DNA is considered as a transcriptionally 
repressive mark (Fig. 1.4.c), in some instances 5mC is able to recruit 
C/EBPα, which is able to bind 5mC and functions as a transcriptional 
activator. In the epidermis, C/EBPα is expressed predominantly in the 
suprabasal layers (Perdigoto et al., 2014). The importance of this 
transcriptional activator in epidermal differentiation is demonstrated by 
hyperplasia of the basal layer and increased apoptosis in the suprabasal 
layer in vivo (Oh et al., 2007) and inhibition of differentiation in vitro (Rishi 
et al., 2010), when normal activity of C/EBPα is repressed.  
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Regulation of the DNA hydroxy-methylation by TET proteins  
The TET protein family comprise TET1, TET2 and TET3 which 
emerged in jawed vertebrates due to triplication of a common ancestor gene 
(Iyer et al., 2009). First evidence validating that hydroxy-methylation was 
carried out by TET1 appeared in 2009 (Tahiliani et al., 2009). Eventually, it 
was shown that TET2 and TET3 are also able to make 5hmC (Ito et al., 
2010; Ko et al., 2010). The structure of TET proteins consists of iron and 
oxoglutarate binding domains and possibly DNA binding domain which is 
cysteine-rich (Iyer et al., 2009). Interestingly, the distribution of 5hmC in the 
genome is distinct from 5mC and is associated with promoters, Polycomb 
mediated gene silencing and gene expression (Branco et al., 2012). 
Furthermore, it is considered that 5hmC exists as an intermediate 
modification before demethylation of 5mC. Currently, there is not enough 
evidence to determine further steps that lead to demethylation. One theory 
is that during replication the hemi-hydroxy methylated DNA is not 
remethylated by DNMT1 (Inoue and Zhang, 2011). However, it was shown 
that UHRF1 that targets DNMT1 to hemi-methylated DNA has similar affinity 
for both 5hmC and 5mC (Frauer et al., 2011), which indicates that an other 
mechanism of demethylation might be present.  
Interestingly, demethylation of methylated cytosine might involve 
further oxidation of the 5hmC by TETs to make formylcytosine (5fC) and 
carboxylcytosine (5caC) (Branco et al., 2012). Both 5fC and 5caC can be 
removed by glycosylases, such as thymine DNA glycosylase (TDG) (Maiti 
and Drohat, 2011). The TDG enzyme has been previously implicated in 
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removal of thymine in the T:G base mismatch and activation of base 
excision repair (BER) (Branco et al., 2012). Surprisingly, the TDG enzyme 
has a stronger affinity to 5fC than to T:G site and is also able to remove 
5caC (Maiti and Drohat, 2011). The accompanying BER mechanism is able 
to insert un-methylated cytosine.  Therefore, multiple methods are likely 
present in demethylation of DNA. The role of TETs in epidermal 
differentiation is not yet understood and requires further research.  
1.3.2. Covalent histone modifications and Polycomb-dependent gene 
silencing  
The genome is organized in a hierarchical manner. Firstly, the genome 
is made up of chromosomes, which represent a largest unit of genome 
organization. Secondly, the chromosomes are made up of nucleosomes. 
Thirdly, one nucleosome consists of ∼ 146 bp of DNA coiled around a 
histone octamer protein complex composed of two H2A-H2B and two H3-
H4 histone heterodimers (Perdigoto et al., 2014).  
Gene transcription is affected by histone modifications which usually 
occur in the amino-terminal part (histone tail) and can involve acetylation, 
methylation, phosphorylation, ADP-ribosylation, arginine deamination, 
proline isomerization, sumoylation and ubiquitination (Perdigoto et al., 
2014). Depending on the location and the type of modification will determine 
the expression state of a gene (Fig. 1.6) (Perdigoto et al., 2014) because 
these modifications alter histone-DNA and histone-histone interactions 
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thereby influencing the accessibility of transcriptional machinery to the DNA 
(Perdigoto et al., 2014).  
Histone methylation and acetylation are the most characterised 
modifications in the epidermis. While methylation is associated with both 
transcriptional activation and repression, acetylation is mostly correlated 
with positive regulation of gene expression (Fig. 1.6.b) (Perdigoto et al., 
2014). These modifications are established by histone methyltrasferase and 
acetyl transferase enzymes and are removed by demethylase and 
deacetylase enzymes (Perdigoto et al., 2014).  
Histone acetylation 
Histone acetyl trasferases (HATs) and histone deacetylases (HDACs) 
are the enzymes which regulate histone acetylation (Campos and Reinberg, 
2009). Hyper- and hypo-acetylation of lysine is associated with activation 
and repression of transcription, respectively, because of the changes in 
chromatin compaction (Campos and Reinberg, 2009). For example, 
chromatin from cells treated with an inhibitor for HDAC, trichostatin A (TCA), 
are less resistant to digestion by endocnucleases (Campos and Reinberg, 
2009). Interestingly, the types of acetylation modifications of an active gene 
differ between the promoter and the coding region of the gene. The 
promoter is enriched with H3K9ac, H3K18ac and H2B12ac and the gene 
has H4K12ac and H4K16ac (Fig. 1.6.c) (Botchkarev et al., 2012). TCA 
treatment decreases cell proliferation in the epidermis (Markova et al., 2007) 
and induces the expression of involucrin in primary keratinocytes (Saunders 
et al., 1999). Deletion of HDAC1 and HDAC2 results in failure of the 
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epidermal stratification and ectopic expression of p21, 14-3-3σ and p16 in 
the ectoderm. (LeBoeuf et al., 2010). The aryl hydrocarbon receptor nuclear 
translocator (ARNT) was found to control expression of epidermal 
differentiation genes through HDAC and EGFR-dependent pathway 
(Robertson et al., 2012).  
Histone methylation  
Mono-, di-, and try-methylation are three types of modifications that 
can occur at histone tails and thereby regulate gene expression. Just like 
with acetylation, genes that are transcriptionally active or silenced also show 
preferential enrichment of specific methylation markers. For example, 
silenced genes are enriched with di- and try-methylation of histone H3 lysine 
9 (H3K9me2/3) and H3K27me3 (Fig. 1.6.c) (Botchkarev et al., 2012; Wang 
et al., 2009). In active genes, these sites are monomethylated along with 
H3K20me1, also H3K4me3 and H3K4me1/2 are present at and around the 
transcriptional start site (Botchkarev et al., 2012; Wang et al., 2009). In 
addition, active genes can have H3K79me2/3 and H3K36me3 at 5’ region 
and at 3’ region, respectively (Fig. 1.6.c) (Botchkarev et al., 2012). 
Furthermore, some gene promoters are enriched in both H3K4me3 and 
K3K27me3 which puts gene transcription in a paused state (Fig. 1.6.c) 
(Botchkarev et al., 2012; Perdigoto et al., 2014; Wang et al., 2009).  
The H3K20me1 histone modification has been studied in more detail 
during epidermal development (Driskell et al., 2012). This mark is catalysed 
by Setd8-mediated histone methylation and is present at transcriptionally 
active genes. Loss of Setd8 results in absence of proliferation and aberrant 
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differentiation of the epidermis (Driskell et al., 2012). The reason for this is 
because Setd8 is a transcriptional target of c-Myc and the absence of p63 
transcription, which is mediated by H3K20me1 (Driskell et al., 2012). 
However, the main reason for loss of proliferation is due to increased 
expression of p53, which promotes cell apoptosis (Driskell et al., 2012). 
Therefore, Setd8 is essential for epidermal proliferation and differentiation.  
The H3K27me3 is a repressive mark which is present at the promoters 
of many genes involved in epidermal differentiation (Sen et al., 2008). One 
of the enzymes that is capable to demethylate this mark and induce gene 
expression is a member of Jumonji C (JmjC) domain-containing proteins, 
JMJD3 (Agger et al., 2007). JMJD3 is crucial for proper regulation of 
epidermal development because depletion of this protein blocks 
differentiation (Sen et al., 2008). 
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Figure 1.6. Distinct levels of chromatin organization. (A), post 
translational modification in histone tails (B), characteristics of the active 
and inactive chromatin domains (C), and epigenetic control of gene 
expression in the epidermal differentiation complex locus (D). Modified from 
(Botchkarev et al., 2012; Perdigoto et al., 2014).  
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1.3.3 Polycomb-dependent gene silencing 
Gene silencing characterised by presence of H3K27me3 is medicated 
by different Polycomb group proteins (PcGs) (Di Croce and Helin, 2013). 
PcGs are able to block RNA polymerase 2 elongation by modulating 
chromatin compaction (Di Croce and Helin, 2013). They perform this 
functions by assembling into larger structures called Polycomb repressive 
complexes (PRCs) (Di Croce and Helin, 2013). Currently, there are two 
types of well-studied PRC complexes that are formed from PcGs, which are 
PRC1 and PRC2 (Di Croce and Helin, 2013). PRC1 is made from four core 
PcGs components, which are RING1, CBX, PCGF and HPH, while PRC2 
consists of three PcGs components, which are EZH, EED and SUZ12 (Fig. 
1.7). An overview of our current understanding of how PRCs carry out their 
gene silencing activity, how they are targeted to chromatin sites and their 
role in epidermal development is described below.  
Mechanisms of PRC recruitment and regulation of gene silencing 
Components of the PRC2 complex, specifically EZH1 and EZH2 are 
responsible for the mono-, di- and tri-methylation of H3K27 (Margueron et 
al., 2008). EZH1/2 require EED and SUZ12 for a functional methyl-
transferase activity (Cao and Zhang, 2004). Genome-wide analysis 
identified a correlation between CpG rich-DNA and H3K27me3 (Ku et al., 
2008). However, only CpG islands which were largely un-methylated and 
did not have any binding sites for transcriptional activators were able to 
recruit PRC2 by unknown mechanism (Mendenhall et al., 2010). 
Interestingly, TETs might be involved in recruitment of PRC2 due to their 
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ability to modify 5mCpG DNA (Wu et al., 2011). A zinc-finger binding protein, 
AEBP2, was found to bind to DNA and recruit PRC2 (Kim et al., 2009). 
Furthermore, another member of Jumonji C (JmjC) domain-containing 
proteins, JARID2, was found to enhance recruitment of PRC2 (Li et al., 
2010) and is important in maintaining epidermal homeostasis (Mejetta et al., 
2011).  
The H3K27me3 provides a docking site for canonical PRC1 because 
this modification mark is recognised by the chromo-domain of the CBX 
component from PRC1 complex. After docking, the E3 ligases RING1a/b 
from PRC1 catalyse mono-ubiquitilation of H2A on K119 (H2AK119ub1), 
which leads to chromatin compaction (Wang et al., 2004). Compacted 
chromatin prevents accessibility of transcription factors and ATP-dependent 
chromatin remodelling machinery (SWI/SNF) (Bantignies and Cavalli, 
2011). Also, it has been shown in vitro that H2AK119ub1 prevents 
methylation of H3K4 (Nakagawa et al., 2008). However, H2AK119ub1 is 
required for reactivation of PRC-silenced genes because this modification 
mark is recognised by zuotin-related factor 1 (ZIF1), which is able to 
displace PRC1 from chromatin and initiate gene transcription (Richly et al., 
2010).  
Until recently, it was believed that the mechanism of Polycomb 
dependent gene silencing consisted of PRC2 mediated tri-methylation of 
H3K27 and then subsequent recruitment of PRC1. However, this view has 
become outdated after the discovery of non-canonical PRC1 which do not 
have the CBX and HPH components (Schwartz and Pirrotta, 2014). 
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Furthermore, it was found that certain CpG islands can recruit PRC1 in 
addition to PRC2 (Wu et al., 2013). Specifically, a non-canonical PRC1 
component called KDM2B targets RING1b via a CXXC zinc finger domain 
to specific loci containing CpG islands in mouse embryo stem cells (Wu et 
al., 2013). KDM2B is unable to bind methylated CpG (Simon and Kingston, 
2013). Therefore, TETs in addition to recruiting PRC2, might, also be 
involved in recruiting non-canonical PRC1 (Wu et al., 2011). Interestingly, 
non-canonical PRC1 mediated ubiquitination of H2AK119 is able to recruit 
PRC2 (Blackledge et al., 2014; Cooper et al., 2014). Remarkably, Kalb et al 
(2014) were able to identify AEBP2 and JARID2 along with PRC2 to be 
present on nucleosomes containing H2AK119ub1. The authors concluded 
that PRC2 complexes containing AEBP2 and JARID2 are able to 
specifically interact with H2AK119ub1 and promote methylation of H3K27 
(Kalb et al., 2014). Also, ablation of PRC1-mediated H2AK119 ubiquitination 
impairs genome-wide PRC2 binding and disrupts mouse development 
(Schwartz and Pirrotta, 2014).   
The role of PRC2 component EZH2 has been studied in the 
development of mouse epidermis. Analysis of genes targeted by PRC2 in 
basal epidermal cells identified the H3K27me3 mark to be associated with 
promoters of almost 4000 genes that are normally expressed in muscle, 
neuronal and hematopoietic cells (Ezhkova et al., 2009). The H3K27me3 
mark was not present among genes that are specifically expressed in the 
basal and early epidermal differentiation cells (Ezhkova et al., 2009). 
However, it was present at numerous promoters of genes involved in late 
epidermal differentiation, which are normally expressed in granular and 
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cornified layers (Ezhkova et al., 2009). Furthermore, EZH2 was highly 
expressed in the proliferative cells of basal layer and was down-regulated 
in the differentiated cells of the suprabasal layer (Ezhkova et al., 2009). 
Absence of EZH2 in the epidermal progenitor cells resulted in up-regulation 
of skin differentiation genes only and accelerated development of skin 
barrier formation (Ezhkova et al., 2009). This data indicated that other 
mechanisms of suppressing non-skin lineage genes must be present. Of 
the most up-regulated genes in the EZH2 depleted basal cells many were 
from the Epidermal Differentiation Complex (EDC), which included genes 
specific to the granular layer such as fillagrin, loricrin, involucring and genes 
of the late cornified envelope family (Zhang et al., 2012). Interestingly, EDC 
locus is the subject of higher order chromatin remodelling due to the activity 
of p63 and Satb1 (Fig. 1.6.d) (Fessing et al., 2011). Additionally, EZH2 
mediated repression of epidermal differentiation genes was achieved by 
prevention of transcription factor (AP1) binding to the target genes 
(Perdigoto et al., 2014). 
Analysis of PRC1 component CBX4 in the human epidermis revealed 
that it regulates proliferation and differentiation of epidermal progenitor cells 
(Luis et al., 2011). Interestingly, Luis et al (2011) have found that SUMO 
ligase activity of CBX4 inhibits stem cells activation and differentiation, 
while, the polycomb activity of CBX4 is responsible for maintaining anti-
senescence. In murine epidermis, Cbx4 plays a crucial role in maintaining 
the epithelial identity and proliferative activity in keratinocytes via repression 
of the selected non-epidermal lineage and cell cycle-inhibitor genes 
(Mardaryev et al., 2016). 
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Figure 1.7. Composition and function of the main Polycomb 
complexes. Modified from (Di Croce and Helin, 2013) 
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1.3.4. Higher order chromatin remodelling and 3D genome 
organisation  
“Higher order chromatin folding or structure” is a term that depicts 
chromatin organization after “beads on a string” model (Fig. 1.6.a) (Ferrai 
et al., 2010). Previously, it has been shown that the 3D organization of 
chromatin within the nucleus is not random. In fact, over a century ago light 
microscopy investigation of the nuclei stained with basic dyes identified 
regions of chromatin that were brighter, therefore, more condensed 
(heterochromatin) and dimmer regions representing expanded chromatin 
(euchromatin). Also, the features of the two chromatin types are different, 
euchromatin is transcriptionally active, contains large number of genes and 
replicates early in the cell cycle, while heterochromatin has low 
transcriptional activity, low number of genes and replicates later in the cell 
cycle (Dimitri et al., 2009). Furthermore, heterochromatin can be split into 
at least two stages: constitutive heterochromatin, which consists of silent 
repetitive regions, centromeres and telomeres, and facultative 
heterochromatin consisting of specific gene loci that can have variable 
states of repression in some cells or activation in other cells depending on 
the cellular context (Dimitri et al., 2009).    
Recent research into the 3D genome organization has revealed that 
the chromosomes in the interphase nucleus take up distinct areas 
(chromosome territories) and genes within a particular chromosomal 
territory are located relative to each other and other nuclear sub-organelles 
in non-random arrangement (Albiez et al., 2006; Cremer and Cremer, 2010; 
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Naumova and Dekker, 2010; Sanyal et al., 2011). These observations have 
been possible due to two experimental techniques. First technique involves 
the analysis of 3D images generated by confocal microscopy of nuclei 
processed using fluorescent in situ hybridization (FISH) or fluorescent DNA 
binding chimeric proteins (Chuang et al., 2006; Joffe et al., 2010; Kumaran 
et al., 2008). Second technique exploits chromosome conformation capture 
technologies such as 3C which involves cross-linking chromatin followed 
by restriction, ligation, PCR and sequencing to identify intra-molecular 
products (Naumova and Dekker, 2010).  
Analysis of the data obtained from chromosome conformation capture 
technologies enable the identification of topologically associated domains 
(TADs). TADs have been defined as “linear units of chromatin that fold as 
discrete three-dimensional (3D) structures tending to favor internal, rather 
than external, chromatin interactions” (Ciabrelli and Cavalli, 2015). TADs 
have been proposed as invariant building blocks of chromosomes. 
Furthermore, chromatin interactions within TADs are cell type-specific, 
thereby linking 3D genome structure with phenotype. Surprisingly, TADs 
were found to be conserved in different animal cell types but absent in yeast 
and plants (Feng et al., 2014; Grob et al., 2014; Moissiard et al., 2012; 
Tanizawa et al., 2010; Tjong et al., 2012).  
It has been demonstrated that genes which are actively transcribed 
are often found associated with each other in active chromatin domain, 
while silent genes also tend to cluster together in the silenced chromain 
domain (Lieberman-Aiden et al., 2009). Furthermore, the process of gene 
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activation or silencing can involve adjustments to the location of the gene 
relative to other domains and/or nuclear bodies (Misteli, 2007; 
Schoenfelder et al., 2010a). 
1.3.4.1. Transcription factories 
Various evidence obtained from immunohistochemistry of 
phosphorylated Serine-5/2 RNA Polymerase 2 isoforms indicated that 
transcriptional factories can form after RNA Pol II-containing pre-initiation 
complexes assembled next to each other in the nuclear space (Cook, 1999; 
Schoenfelder et al., 2010a). Furthermore, large number of genes located 
on the same or different chromosomes which are transcriptionally active at 
the same time sometimes share a single transcriptional factory made from 
a unique combination of transcription factors and transcription facilitating 
molecules  (Eskiw et al., 2010; Razin et al., 2011). Remarkably, such an 
event does occur in the erythroid cells where Hbα/β globin genes and 
hundreds of transcribed genes from various chromosomes aggregate in 
transcription factories enriched by a transcription factor Klf1 (Schoenfelder 
et al., 2010b). Therefore, specific transcription factories may function as 
hubs where tissue and cell-type specific inter- and intra-chromosomal 
interactions occur to coordinate expression of genes required for 
differentiation programs (Chakalova and Fraser, 2010).  
Cell type-specific repositioning of genes from the nuclear periphery to 
nuclear interior is frequently seen through the course of development 
(Egecioglu and Brickner, 2011).  This has been observed in human primary 
keratinocytes where the EDC located on chromosome 1 forms a loop 
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outside of the chromosomal territory (Williams et al., 2002). Repositioning, 
however, might not apply to all active genes because many of them are 
expressed inside the chromosomal territories (Mahy et al., 2002a; Mahy et 
al., 2002b). Gene repositioning during development could be interpreted as 
a way to reach an environment that is suitable to maintain or regulate gene 
expression (Lanctot et al., 2007). In developing mouse epidermis, EDC 
locus show remarkable developmentally regulated repositioning from 
nuclear periphery towards nuclear interior, which is associated with marked 
increase of transcription of terminal differentiation genes (Mardaryev et al., 
2014). In differentiating epidermalin keratinocytes, EDC tends to cluster 
around nuclear speckles localized in the interchromatin compartments 
(Mardaryev et al., 2014) possibly because speckles provide a permissive 
environment for transcription, also, they are enriched with RNA splicing 
machinery (Hu et al., 2008; Spector and Lamond, 2011). Interestingly, it 
was shown that the relocation of genes promoting proliferation from 
repressive Polycomb bodies to speckles is associated with the methylation 
and demethylation of CBX4 component of the canonical PRC1 protein 
complex. Methylated and demethylated forms of CBX4 can attach to non-
coding RNA TUG1 and non-coding RNA MALAT1/NEAT2, located at 
Polycomb bodies or speckles, respectively (Yang et al., 2011). 
MALAT1/NEAT2 mediated interactions with many transcription and/or 
splicing factors results in gene activation after their relocation to the 
speckles (Yang et al., 2011).    
It was recently demonstrated that genetically engineered mice with 
ablation of either Keratin type I or type II loci from chromososmes 11 and 
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15, respectively display perinatal mortality and severe barrier (Kumar et al., 
2015). Absence of keratins seriously compromises epidermal development 
and prenatal (E18.5) pups display a hyperthickened, fragile epidermis with 
smaller and fewer desmosomes, leading to intercellular adhesion defects 
(Bar et al., 2014). Epidermis of KtytII-/- showed a compact stratum corneum 
and apparent absence of filaggrin and locricrin-positive keratohyalin 
granules confirmed by electron microscopy, compared to controls (Kumar 
et al., 2015). Global gene expression analysis of back skin RNA from KtyII-
/- and control littermates at E18.5 showed that of the 61 genes located on 
the EDC (de Guzman Strong et al., 2010), 15 encoding structural CE 
components, among them loricrin, filaggrin 2, hornerin (Hrnr) and late 
cornified envelope group1 genes (Lce1), were strongly downregulated in 
KtyII-/- mouse skin. However, 22 genes including small proline-rich genes 
(Sprrs), S100A8 and late cornified envelope group 3 genes (Lce3), 
connected to oxidative stress, barrier defects and hyperproliferative skin 
conditions, were upregulated upon Keratin type II locus ablation (Kumar et 
al., 2015). This study suggests the complexity of interactions between 
lineage-specific gene loci in the nucleus that link keratin scaffolds to 
epidermal barrier formation and maintenance.    
1.3.4.2 Long-range chromatin interactions 
“Transcriptional interactome” refers to cell type specific transcriptional 
profile which is the outcome of long-range inter- and intra-chromosomal 
associations that occur between different genomic regions (Cope et al., 
2010; Schoenfelder et al., 2010a). These kind of interactions can be 
observed during Ca2+-stimulated primary keratinocyte differentiation where 
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enhancer and promoter of the peptidylarginine deiminase 3 gene, which 
regulates metabolism of fillagrin, come together (Chavanas et al., 2008). 
Energy dependent process of gene relocation or other distant interactions 
with in the nucleus is mediated, at least partially, by actin-myosin nuclear 
motor complexes (Botchkarev et al., 2012; Chuang et al., 2006).  
Furthermore, a number of proteins are associated with the function of 
genome organization by creating loop-like structures inside (cis-) the 
chromosomes and between (trans-) the chromosomes. These proteins 
include Ctcf, cohesin and Satb1 (Cai et al., 2006; Merkenschlager, 2010; 
Ohlsson et al., 2010).  
Satb1 plays an important role in governing tissue-specific gene 
expression programs by regulating 3D chromatin conformations via the 
targeting of remodeling enzymes and transcription factors to distinct 
genomic regions (Cai et al., 2006). The role of Satb1 has been studied 
during epidermal development and it was found to control conformation of 
the EDC locus, which contains differentiation genes (Fessing et al., 2011). 
Deletion of Stab1 causes the elongation of EDC within the 3D nuclear 
space, as a consequence gene expression and epidermal morphology are 
aberrant (Fessing et al., 2011). Therefore, 3D organization of tissue-
specific genomic loci plays a role in the regulation of transcription programs 
and gene expression outcomes. Other key proteins implicated in generating 
3D loop structures are Ctcf and cohesin.  
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1.3.4.3. CTCF as a master chromatin architectural protein involved in 3D 
genome assembly  
CTCF is able to bind DNA and is likely involved in the formation of 
thousands of loops in the genome (Fig. 1.8), which can bring genes from 
different chromosomes into close proximity (Ohlsson et al., 2010). Also, 
CTCF recruits cohesin which is crucial for regulating chromosomal 
segregation during mitosis (Hadjur et al., 2009). Furthermore, cohesin 
controls conformation and gene expression as described in T-cell receptor 
locus where CTCF-cohesin complex mediates promoter-enhancer 
associations and maintains transcription and boundary of the locus from 
scattered elements and neighboring housekeeping genes 
(Merkenschlager, 2010; Seitan et al., 2013). 
Much evidence has been generated to implicate CTCF in TAD 
formation. Firstly, TAD borders were found to be enriched for CTCF biding 
sites. Secondly, CTCF depletion in cells results in decrease in intradomain 
interactions, while, interaction between adjacent TADs are increased 
(Reviewed in Ong and Corces, 2014). Thirdly, this 11 zinc finder DNA 
binding protein is heavily conserved among animals, while it is absent in 
yeast and plants (Reviewed in Ong and Corces, 2014).  
The CTCF target consensus DNA binding sequence (Fig. 1.9) 
contains CpGs indicating that methylation of cytosine can play a role in 
CTCF binding selectivity (Engel et al., 2004). This has been confirmed with 
one study showing that in 19 human cell types 41% of cell type specific 
CTCF-binding sites are linked with methylation status (Wang et al., 2012). 
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Surprisingly, CTCF itself can maintain a de-methylated state of DNA by 
binding and activating PARP1 which in turn turns off DNMT1 (Guastafierro 
et al., 2008; Zampieri et al., 2012). Hydroxymethylation of 5mC by the TET 
enzymes provide another level of complexity to this process (Ito et al., 2011; 
Kriaucionis and Heintz, 2009; Tahiliani et al., 2009). 
Presence of CTCF biding sites that are not methylated suggest 
another regulatory mechanism of DNA occupancy by this protein. 
Posttranslational modification of CTCF is another mechanism. For 
example, incorrect poly(ADP-ribosy)lation of CTCF has been linked with 
CTCF removal from the tumour suppressor CDKN2A locus resulting in 
silencing of the p16(INK4a) gene in human breast cancer due to 
methylation of CpG by DNMT1 (Witcher and Emerson, 2009). 
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Figure 1.8. Model of chromosome folding involving CTCF and RNA 
Polymerase II. Modified from (Tang et al., 2015).  
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 Further mechanisms of CTCF targeting to DNA sites can be due to 
interactions with other proteins. A number of proteins have been confirmed 
in CTCF function such as PARP1, YY1, MAZ, JUND, ZNF143 (Reviewed 
in Zlatanova and Caiafa, 2009). However, only cohesin has been found to 
be essential for stabilizing most CTCF-chromosomal contacts (Reviewed in 
Ong and Corces, 2014). The SA2 subunit of cohesin can interact with the 
carboxy-terminal part of CTCF (Xiao et al., 2011). Disruption of cohesin 
expression also alters intrachromosol interactions mediated by CTCF 
(Hadjur et al., 2009; Hou et al., 2010; Nativio et al., 2009). Interestingly, 
another protein that can possibly interact with CTCF is TFIIIC, which along 
with RNA polymerase III is involved in transcription of tRNAs, 5S rRNA, 
non-coding RNA (ncRNA) and B2 short interspersed nuclear elements 
(SINEs) (Fig. 1.9) (Kirkland et al., 2013). CTCF and cohesin have been 
found associated with genomic locations containing tRNA genes as well as 
TFIIIC bound sites that are devoid of Pol III in mouse and human cells 
(Carriere et al., 2012; Moqtaderi et al., 2010; Oler et al., 2010).  
Other data has showed that RNAs are also involved in stabilizing 
CTCF interactions with other proteins. For example, CTCF had been 
implicated in binding to both the DEAD-box helicase p68 and its associated 
ncRNA (Yao et al., 2010). The ncRNA was found to be important for the 
correct CTCF function (Yao et al., 2010). This data indicates that ncRNAs 
do play a role in stabilizing CTCF-mediated interactions. 
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Figure 1.9. Key features of Ctcf binding sites. (Modified from Ong and 
Corces, 2014).  
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Ctcf has also been implicated in inter-chromosomal associations that 
are able to regulate gene expression. This has been shown in CD4+ T cells, 
which upon antigen stimulation can differentiate into three types of helper 
cells, Th1, Th2 and Th17 which express IFN-gamma, IL-4, and IL-17, 
respectively (Kim et al., 2014). Interestingly, using 3D-FISH it was shown 
that the locus containing IFN-gamma has been found to be associated with 
Th2 locus, and Th2 locus can associate with IL-17 locus (Kim et al., 2014). 
Differentiation into Th17 cells was found to be restrained by the association 
with the Th2 locus and this was orchestrated by Oct-1 and CTCF (Kim et 
al., 2014). The association was found to require an Oct-1 biding site at the 
DNase I hypersensitive region (RHS6) of the Th2 locus and the IL-17 
promoter of IL-17 locus. Deletion of RHS6, Oct-1 or CTCF deficiency all 
impaired the association, which resulted in enhanced IL-17 expression, 
paralleled by an increased frequency of IL-17-producing cells during early 
during differentiation of naive T cells toward the Th17 lineage (Kim et al., 
2014).  
Whether gene expression in the keratinocyte-specific genomic loci 
is affected as a result of CTCF-mediating inter-chromosomal associations 
is yet to be determined. Also, the phenotype of skin deficient for CTCF is 
unknown. However, some data exists for cohesin-SA1 in skin development. 
The cohesin-SA1 null embryos (E17.5) had thinner skin with reduced 
number of hair follicles (Remeseiro et al., 2012). Mircroarray analysis of 
cohesin-SA1 null mouse embryonic fibroblasts identified that expression of 
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gene cluster involved in skin function was affected (Remeseiro et al., 2012). 
These clusters were predominantly located in the keratin type I and keratin 
type 2 locus. Furthermore, Ctcf Chip-Seq data obtained by Dr Andrei 
Mardaryev (University of Bradford) had showed Ctcf biding sites within 
various regions of the EDC locus (Fig. 1.10). Thus, the data suggest that 
CTCF is likely to also be involved in the control of skin development and 
keratinocyte differentiation.  
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Figure 1.10. Ctcf Chip-Seq Peaks on the Epidermal Differentiation 
Complex. Experiment carried out by Dr Andrei Mardaryev (University of 
Bradford) and analyzed by Dr Krzysztof Poterlowicz (University of 
Bradford).  
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1.3.4.4. Heterochromatin  
Heterochromatin is closely linked with repressive epigenetic marks 
such as 5meCpG and H3K9me3, as well as other proteins that participate 
in chromatin remodeling, such as Heterochromatin Protein 1 (HP1) (Kwon 
and Workman, 2011; Probst and Almouzni, 2011). Interestingly, there are 
three specific heterochromatic domains which are not transcriptionally 
active. First, domains associated with centromeres is depicted by DNA 
methylation, H3K9me3, H3K20me3 and α/β/γ HP1 isoforms.  Second, 
domains enriched by H3K9me2 and HPα/β associated with nuclear lamina. 
Third, domains depicted by H3K27me3 and PcGs (Meister et al., 2011; 
Probst and Almouzni, 2011). Even though all of the heterochromatins 
contain some genes that are actively transcribed majority of the genes 
present there are silenced either permanently at the centromeres or 
temporarily in a manner that is developmentally-regulated by PRCs or 
lamina association (Meister et al., 2011).  
HP1 isoforms α, β and γ, which are encoded by chromobox genes 
CBX5, CBX1 and CBX3, respectively, play vital roles in the 
heterochromatin formation. HP1α/β binds H3K9me3 and Lamin B receptor 
thereby maintaining lamina-associated heterochromatin and transcriptional 
repression, in contract HP1γ interacts with euchromatin by binding to the 
elongating of Polymerase II via histone chaperone FACT and positively 
regulating transcription (Black and Whetstine, 2011; Kwon and Workman, 
2011).  
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Polycomb proteins are indispensable when it comes to maintaining a 
repressed state of the chromatin. Polycomb proteins interact with polycomb 
response elements and gene promoters to form repressive structures and 
maintain gene silencing (Lanzuolo et al., 2007). In fact, the silenced 
chromatin loops might be organized in the nucleus into Polycomb bodies 
which can be considered as chromatin silent factories that contain 
repressors of transcription such as non-coding RNA TUG1 (Aamodt et al., 
2011; Yang et al., 2011). So far it is unclear how such repressive factories 
contribute to differentiation of the epidermis.   
To summarize, there are two key epigenetic mechanism that modulate 
local and higher order chromatin architecture of keratinocytes. These 
include: 1) controlling the expression of genes associated with terminal 
differentiation; and 2) regulating cell-cycle associated gene expression. For 
example, repressive chromatin regulators (DNA methyltransferase 
DNMT1, histone deacetylases HDAC1/2, Polycomp components Cbx4, 
Bmi1, Ezh1/2) function by stimulating proliferation of progenitor cells via 
repression of the genes encoding cell-cycle inhibitors p16INK4A, 
p15INK4B, p21 and p19ARF. Furthermore, several repressive chromatin 
regulators (DNMT1, Ezh1/2, Jarid2) also prevent premature activation of 
terminal differentiation-associated genes, whereas HDAC2 inhibits 
expression of deltaNp63 and interfere with deltaNp63-regulated gene 
expression program in keratinocytes.  
Conversely, terminal keratinocyte differentiation is promoted by 
chromatin remodelers that generally support active transcription and exhibit 
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effects on cell proliferation (histone demethylase Jmjd3, ATP-dependent 
chromatin remodeler Brg1, genome organizer Satb1). Most likely 
expression of genes associated with terminal differentiation including EDC 
genes of epidermal keratinocytes involves highly coordinated action of 
several epigenetic regulators that operate at both levels of local (DNMT1, 
Ezh1/2, Bmi1, Jarid2, Jmjd3, Brg1) and higher-order (Satb1) chromatin 
structures.  
In this Thesis, the mechanisms regulating higher-order chromatin 
remodeling in skin epithelial cells are explored using a complex approach 
including microarray and qRT-PCR gene expression analyses, 3D-FISH 
studies of gene topology in the nucleus, keratinocyte-specific gene 
targeting and in vivo analyses of skin phenotype in genetically engineered 
mice. In particular, the results of analyses of three-dimensional organization 
of lineage-specific gene loci in epidermal keratinocytes using 3D-FISH 
technique are presented in Chapter 3.1. Furthermore, the effects of the 
genetic ablation of the gene encoding chromatin architectural protein Ctcf 
on skin development and post-natal regeneration are described in the 
Chapters 3.2-3.4. The results of these experiments are discussed in the 
Chapter 4 and conclusions are summarized in Chapter 5.      
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1.3. Aims and Objectives of this study 
 
The aims of this study are to study three-dimensional organization of the 
lineage-specific gene loci in keratinocytes and explore the mechanisms that 
control higher-order chromatin remodelling and activity of lineage-specific 
genes in the skin epithelium. 
These aims will be achieved via three distinct Objectives:    
1. To study three-dimensional organization of lineage-specific gene loci 
(Keratin type I/II loci, Epidermal Differentiation Complex locus) in 
epidermal keratinocytes and define how genetic ablation of the 
Keratin type II locus in mouse epidermis affect three-dimensional 
nuclear architecture and nuclear positioning of the Epidermal 
Differentiation Complex locus. 
2. To explore the mechanisms that control higher-order chromatin 
organization and remodeling in epidermal keratinocytes during 
murine skin development and define the role of Ctcf in the control of 
epidermal development and keratinocyte differentiation in mouse 
skin. 
3. To delineate the role of Ctcf in the control of epidermal barrier 
maintenance and terminal keratinocyte differentiation in the 
epidermis of postnatal skin. 
 
 
MATERIALS AND METHODS 
61 
 
 
 
 
 
 
 
 
 
 
 
2. MATERIALS AND METHODS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
62 
 
2.1. Animals and tissue collection 
Skin samples of Keratin Type I and Type II knockout mice (P0-P9) for 3D- 
FISH analyses were provided by Thomas Magin’s laboratory (Leipzig 
University, Germany) as part of collaboration. All other skin samples were 
obtained from mice being housed at the University of Bradford animal facility 
under the approval of PPL 40/2989 licence.  
The skin samples were collected from the embryos (E14.5, E16.5, E18.5) 
or postnatal wild-type C57Bl6 mice (P1.5-P19.5). Hair cycling was induced 
in 8 week-old mice by depilation and skin was collected at different time 
points post-depilation (days 0 p.d. – 21 p.d.).  
Targeted keratinocyte-specific Ctcf deletion using Cre-Lox recombination 
technology was used to study the role of Ctcf in the control of skin 
development and postnatal homeostasis. Ctcf fl/fl mice (generated by Heath 
et al., 2008) were crossed with tamoxifen-inducible transgenic mouse 
expressing Cre recombinase/estrogen receptor under the control of 
Cytokeratin 14 promoter. The K14-Cre/ER-Ctcf fl/fl mice were 
intraperitoneally injected with tamoxifen. This included injecting time-mated 
mice at E12.5 for three days, followed by the harvesting of embryos at E16.5 
and E18.5. Furthermore, 8-week old adult mice were shaved and tamoxifen 
was applied topically, as well as by intraperitoneal injection for three days 
and skin samples were collected at 5, 7, 9 and 12 days after the start of 
treatment. All embryos and skin samples were embedded in OCT (Optimal 
Cutting Temperature compound), quickly frozen in liquid nitrogen and stored 
at -80oC until use.  
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2.2. Immunohistochemistry 
2.2.1. Sample preparation 
Skin samples were cut using cryostat Microm HM550 (Thermo 
Scientific) at -30⁰C (section thickness - 10µm), which were collected onto 
adhesive SuperFrost Plus slides (VWR International, Cat. No: 631-0447) 
and then stored at -80⁰C. 
2.2.2. Immunofluorescence procedure 
Slides with tissue sections selected for immunostaining were removed 
from the freezer and air-dried at room temperature (RT) for 10 minutes 
(min). In addition, PAP pen was used to highlight areas around the sections. 
Tissue was fixed in 4% (w/v) paraformaldehyde for 10 min at RT in a 
coupling jar. Slides were washed 3 times for 5 min in 1xPBS plus 0.05% 
(v/v) Triton X-100. Primary antibody diluted in a loading buffer, prepared as 
described below, was then applied onto sections and incubated overnight 
at +4⁰C.  
Antibody loading buffer consisting of 1% (w/v) BSA (Bovine Serum 
Albumin), 0.1% (v/v) Triton X-100, 0.1% (w/v) Saponin, 1xPBS (10mM PO43-
, 137mM NaCl, 2.7mM KCl) was prepared and antibodies with appropriate 
dilution factor were added (Table 2.2). 
After incubation with the primary antibody, sections were washed in 
1xPBS 3 times for 5 min. Secondary antibody diluted in 1% (w/v) BSA was 
then applied onto sections and incubated for 1 hour at +37⁰C. Slides were 
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washed again in 1xPBS 3 times for 5 min. Vectashield mounting medium 
with DAPI and cover slip were then applied onto slides. 
Table 2.1. List of primary and secondary antibodies used 
Primary antibody Dilution Origin  
Rabbit anti-Ctcf (1:1000) Cell Signaling (2899S) 
Guinea pig polyclonal anti-
K14 (1:100) Abcam  
Rabbit polyclonal anti-K10 (1:100) Abcam (AB76318) 
Rabbit polyclonal anti-Lor (1:100)  Covence (PRB-145p-100) 
Rabbint Anti-CD3  (1:100)  Abcam ab5690 
Rat Anti-CD4 (1:100) PharMingen 
Rat Anti-CD8 (1:100) PharMingen 
Goat Anti-Lhx2 (1:100) Santa Cruz (sc-19344) 
Secondary antibody Dilution Origin  
Goat anti-rabbit/guinea pig 
Alexa Fluor 488/555 (1:200) Life technologies 
 
TUNEL staining for apoptosis was carried using ApopTag Fluorescein In 
Situ Apoptosis Detection Kit (Millipore, S7110) 
2.2.2. Fluorescence microscopy 
Immunostaining was observed using fluorescent microscope Nicon 
Eclipe 50i and images taken using software ImagePro Express 6.3 
connected to IMAGING camera (SN: Q26824). 
2.2.3. Haematoxylin and Alkaline Phosphatase Staining 
Before Alkaline Phosphatase Staining (APS) the following solutions 
were made up: 
Solution A (30 mM Tris base, 7mM TrisHCl, 100mM NaCl) made up to a 
volume of 60ml.  
MATERIALS AND METHODS 
65 
 
 
Solution B (4M Sodium Natrite, 4mM New Fuchsin) made up to a volume 
of 420µl if Solution A was made up to 60ml.  
Solution C (600mM of Naphthol dissolved in Dimethylformamide) made 
up to 360 µl if Solution A was made up to 60ml.  
 Staining for Alkaline Phosphatase was carried out as previously 
described (Lewis et al., 2014; Sharov et al., 2006). First, slides with 
cryosections were air-dried at RT for 10min, fixed in acetone at -20oC for 10 
min and washed twice in PBS, and were then placed into the APS solution 
(prepared immediately before staining by first mixing solution A and solution 
B, then by adding solution C) in a coupling jar for 15 min. Then, slides were 
washed, in 2xPBS for 5 min, and 300-500µl of haematoxylin was added to 
each slide for 40-60 seconds. The slides were then washed under running 
water for 5 min in a coupling jar and the sections were sealed with mounting 
medium and cover slip.  
2.2.4. Bright-field microscopy 
Slides were visualised using Brightfield Microscopy (Nicon Eclipe 
50i) at 10X magnification using ACT-2U software connected to Nikon 
SU41 camera (Lewis et al., 2014).  
2.2.5. Analysis of the epidermal thickness 
 Bright-field images of skin were processed and analysed using 
ImageJ software (NIH). Randomly selected areas of the epidermis were 
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used to measure distances from the basal layer up to the cornified layer of 
tamoxifen-treated and control skin. The mean distance was calculated from 
2-3 animals and Student t-test was performed to identify any significance 
(Mardaryev et al., 2014).    
2.2.6. Analysis of hair follicle development 
Images of skin from AP stained E18.5 were collected from tamoxifen-
treated and control animals. The hair follicles were counted and assigned 
into a stage of development category as described in (Paus et al., 1999). 
Then, percentage of hair follicles in each category was calculated for each 
animal. A mean value was determined from 2-3 animals in treatment and 
control groups and Student t-test was performed for each stage of hair 
follicle development.  
2.2.7. Analysis of epidermal proliferation  
 Fluorescent images of E16.5 and E18.5 skin stained for Ki67 
proliferation marker was analysed using ImageJ software. Number of cells 
with high intensity of fluorescent signal for Ki67 in the basal cells were 
counted from at least 2 animals in both the treatment and control groups. 
Mean values were obtained and Student’s t-test was used to compare 
treatment and control groups.  
2.2.8. Analyses of the epidermal barrier defects 
Freshly isolated skin from adult mouse was dehydrated in the series of 
methanol/PBS solution (25% (v/v), 50% (v/v), 75% (v/v)) for 1 min each 
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followed by incubation in methanol for 1 min. The skin was rehydrated in the 
same series of methanol/PBS solutions, followed by rinsing in PBS. 0.1% 
(w/v) Toluidine Blue solution was applied on top of the skin and incubated 
for 15 min at RT, as described previously (Kumar et al., 2015). Skin samples 
were then washed extensively in PBS and water, and images were taken 
using digital camera.  
2.3. 3D Fluorescent in Situ Hybridization (3D FISH) 
The general procedure of 3D FISH experiment involved three steps. The 
first step involved wet laboratory experiments, in which fluorescently 
labelled DNA probes were applied to mouse skin sections, which hybridised 
to the complementary genomic DNA in the nuclei of the mouse cells. The 
second step involved using confocal microscopy to obtain 3D images of the 
mouse nuclei and the fluorescent probes. The third step involved the 
determination of the exact position of the fluorescent probes within the 
nucleus and further statistical analysis of these results.  
2.3.1. Sample preparation 
The mouse samples used for this study included FISH fixed dorsal skin 
of genetically modified mice (P0-P8) with a deletion of the Keratin Type 2 
locus. These samples were provided by Prof. T. Magin (University of 
Leipzig, Germany). In addition, skin samples for 3D-FISH were obtained 
from C57Bl6 mice (E17.5, P0-P60), as well as from Krt14-CreER/Ctcf fl/fl 
mice (P60) housed at the animal centre at the University of Bradford.  
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The FISH fixation procedure was carried out as follows. Skin samples 
were rinsed in PBS pH 7.4, 2x 5 minutes, room temp. Then, each sample 
was transferred to a separate 15ml falcon tube and fixed overnight at 4°C 
in PFA 4% (w/v). The next day fixative was removed and the falcon tubes 
were filled with 50mM NH4Cl solution, inverted and incubated for 5 min at 
room temp. Afterwards, the samples were washed twice for 10 min in 0.1 M 
phosphate buffer.  The samples were then subjected to the following 
incubations with increasing concentrations of sucrose solution. First, 5 % 
(w/v) sucrose solution was applied to samples for 60 min at RT. Second, 
10% (w/v) sucrose solution was applied 10 min at RT. Finally, samples were 
incubated overnight in 20% (w/v) sucrose solution at 4°C. The samples were 
then transferred to embedding cups and after being covered with 
embedding medium were completely frozen in a dry ice/ethanol bath. The 
samples were then transferred and stored at -80°C freezer until sectioning.  
The sectioning of the samples was performed using cryostat Microm 
HM550 (Thermo Scientific) at -30⁰C with a final section thickness of 14µm, 
which were collected onto adhesive SuperFrost Plus slides (VWR 
International, Cat. No: 631-0447) and then stored at -80⁰C until further use 
in the FISH experiment. 
Preparation of thymocytes 
Thymcytes for 3D FISH experiments were extracted from 6-8 week old 
C57/Bl6 mice as follows. The thymus was placed on ice in a 6-well plate 
containing approximately 5ml of RPMI medium (Gibco) supplemented with 
10% (v/v) FBS (Gibco) and epithelial tissue was mechanically removed from 
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the thymus. The cell lysate was filtered through a 70 µm nylon filter (BD 
Bioscience) and centrifuged at 200g for 10min at 4oC. After discarding the 
supernatant, the cell pellet was resuspended in 3ml of Red Blood cells lysis 
Buffer (Sigma-Aldrich) and incubated for 3 minutes at RT. Cells were then 
diluted with RPMI medium and centrifuged at 200g for 10min at 4oC. The 
supernatant containing lysed red blood cells was discarded and the cell 
pellet was resuspended in RPMI medium supplemented with 10% (v/v) FBS 
(~35-40ml) and filtered through a 70 µm nylon filter.  
Meanwhile, microscope slides were coated with polylysine as follows. 
Slides were placed into 80% (v/v) ethanol for 5 min followed by 1 hour 
incubation with 150 µl of polylysine hydrobromide (1mg/ml) (Sigma-Aldrich) 
at RT. Next, slides were rinsed with ddH2O and air dried. Approximately 1ml 
of culture medium, containing from ~1×105 to ~1×106 cells, was placed on 
a polylysine-coated slide. Slides were incubated in an incubator at 33oC 
containing 8% CO2 for 1 hour. After incubation, each slide was checked 
under the microscope for attachment and the medium was drained off. 
Slides were then incubated in 0.3X PBS for 40 seconds.  
Thymocytes cells attached to slides were then fixed in 4% (w/v) 
PFA/0.3X PBS for 10 minutes at RT, followed by three washing in 1X PBS. 
Slides were then incubated in 0.5% (v/v) Triton X-100/1X PBS at RT for 20 
minutes, transferred to 20% (v/v) Glycerol/1X PBS and incubated  at RT for 
30 minutes. Cells were frozen by dipping slides into liquid nitrogen (~ 30 
seconds) and thawing them on a paper towel. As soon as the slides were 
thawed they were placed back into 20% (v/v) Glycerol/1X PBS solution. The 
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process was repeated four times.  Then the slides were washed in 0.05% 
(v/v) Triton/1X PBS and a final incubation in 0.1 N HCl for 5 minutes followed 
this step. 
Slides were incubated in 2X SCC/50% (v/v) Formamide from overnight 
up to a few weeks at 4oC. Slides were then used for 3D FISH experiments.  
2.3.2. Labelling of BAC probes 
Bacterial Artificial Chromosomes (BACs) containing the desired 
sequences were chosen using a Clone Finder tool available at the National 
Center for Biotechnology Information and ordered from the mouse genomic 
library kept in the BACPAC Resource Center (BPRC) at the Children’s 
Hospital Oakland Research Institute in Oakland, California. The following 
BAC clones were used in the study.  
 
 Table 2.2. Description of BACs used for probe synthesis. 
BAC 
name Chromosome 
BAC 
size 
BAC 
start 
BAC 
finish Build 
gene 
start 
RP24-
61G19 3 183808 91946069 92129877 36.1 Lor 
RP24-
355I20 15 211830 1.02E+08 1.02E+08 36.1 krt2 
RP24-
171O2 15 164238 1.01E+08 1.01E+08 38.1 Ankrd33 
RP24-
177N5 15 175712 1.02E+08 1.02E+08 38.1 Eif4b 
 
BACs were shipped as LB agar stab culture. Single colonies were 
obtained after growing overnight at 37°C on LB agar plate containing 
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20µg/ml of chloramphenicol. These colonies were inoculated into 3ml of LB 
media inside a 50ml falcon tube supplemented with 20µg/ml of 
chloramphenicol and grown overnight at 37°C on a shaker (300rmp). 
Glycerol stocks for long term storage were prepared and stored at -80°C. 
The rest of the LB media containing bacteria culture was used to isolate 
DNA as described below.  
Firstly, the following solutions were prepared: 
P1 solution (4oC): P2 (RT): P3 (4oC) 
50mM tris, pH 8 0.2 M NaOH 3M NaOAc (Sodium 
Acetate) 
10mM EDTA 1% (w/v) SDS pH 5.5 
 
Second, falcon tubes were centrifuged at maximum speed for 10 min 
at RT and supernatant was discarded. Then, the pellet was resuspended in 
0.3ml P1 solution, transferred to 1.5 Eppendorf tube and 0.3ml of P2 
solution was added. After the mixture was incubated for 5 min at RT 0.3ml 
of P3, solution was slowly added and the tubes placed on ice for at least 
5min. Next, the tubes were centrifuged at maximum speed for 10 min at 4°C 
and placed on ice. Next, supernatant was transferred to a different 1.5ml 
Eppendorf tube containing 0.8ml of ice-cold isopropanol, the tubes were 
inverted and placed on ice for 5 minutes. Next, the tubes were centrifuged 
at maximum speed for 15 min at 4°C and supernatant discarded. The pellet 
was washed using 0.5ml of 70% (v/v) Ethanol. After centrifugation at 
maximum speed for 5 min at 4°C the supernatant was discarded. Finally, 
pellets were air dried at RT and resuspended in 20µl TE buffer.  
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Amplification of BAC DNA  
BAC DNA isolated from E.coli was amplified with illustra GenomiPhi 
V2 DNA Amplification Kit according to the supplied protocol (GE Health 
Care Life Sciences, Cat. No: 25-6600-30). Kit contains random hexamer 
primers, the DNA polymerase of Bacillus phage phi29, nucleotides and 
buffers. The kit was used to amplify the isolated BAC DNA and the results 
were checked by electrophoresis on the 1% (w/v) agarose gel.    
Labelling of BAC probes 
Nick translation (NT) is a method of DNA labelling using DNA 
polymerase I. Labelled dUTPs (provided by Dr M.Fessing), including FITC-
dUTP, Bio-dUTP, Dig-dUTP, were used as the DNA labelling components 
of the BAC probes. This method works because DNA polymerase I has a 
5’-3’ exonuclease activity that mediates nick translation during DNA repair, 
as well as the 5’-3’ polymerase activity. Deoxyribonuclease I (DNase I) was 
used to generate random damage in the BAC probe DNA resulting in single 
strand nicks. The DNA polymerase I repairs these nicks using the labelled 
dUTPs.  
The following solutions for NT were prepered: 
i) dNTP mixture (400µl): 
 100µl  2mM dATP  
100µl  2mM dGTP 
100µl  2mM dCTP 
20µl  2mM dTTP  
80µl  H2O 
MATERIALS AND METHODS 
73 
 
ii) 10xNT buffer (100ml): 
50ml  1M Tris-HCl pH 7.5 
 5ml  1M MgCl2 
 50mg  BSA 
 45ml  H2O  
iii) 0.1M Mercaptoethanol:  
 0.1ml  Mecaptoethanol  
14.4ml H2O     
iv) DNase I (grade II, from bovine pancreas) Roche: Cat No: 104 159 
(100mg): 
1mg/ml in 0.15M NaCl in 50% (v/v) glycerol 
v) Stop Mixture:   
50mg  Bromphenolblue 
 250mg Dextanblue 
 1ml  5M NaCl 
 2ml  0.5M EDTA pH8 
 1ml  1M Tris-HCl pH7.5 
The DNase I was diluted to a ratio of 1:250 in cold water and kept on ice, it 
was then used in the following NT reaction prepared on ice in a 0.2ml PCR 
tube: 
Reagent Amount Final Concentration 
2ug DNA (GenomiPhi BAC 
amp) 
5µl  
NT-buffer 10X 10µl 50mM Tris-HCl, pH7.5; 5mM 
MgCl2; 50ug/ml BSA 
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β-mercaptoethanol (100mM) 10µl 10mM 
dNTPmix(0.5mM ACG, 
0.1mM T) 
10µl 50µM for ACG, 10uM for T 
Modified dUTP 1mM 5µl, 10µl 
(fluoro-
dUTP) 
20µM; 40µM for flurochrome 
labelled nucleotide 
ddH2O To 100µL - 
DNase 1 (2,000U/ml) 2µl 0.008U in 100µl reaction 
Polymerase 1 (Promega, 
#M205A) 
2µl 0.1U/µL 
 
The above reaction was incubated at 15°C for 90 min-120min. The length 
of the resulting DNA fragments was checked with an aliquot of 5 µL on a 
1% (w/v) agarose gel (See Figure 3.1 for an example).  
2.3.3. Chromosome Painting 
The second amplification of flow sorted DNA of the mouse 
chromosomes 3 and 15 (obtained from Prof. T. Cremer, Munich University, 
Germany) was firstly amplified by DOP-PCR method in which DNA is 
amplified by PCR reaction with degenerated 6MW primers. Similar method 
was used to label the amplified chromosomal DNA with labelled dUTPs.  
Chromosomal amplification with DOP-PCR 
The 6MW primer with the following sequence, 5’– 
CCGACTCGAGNNNNNNATGTGG -3’ (Eurofins MWG GmbH, Ebersberg, 
Germany), was used to amplify chromosomes 3 and 15. The reaction was 
set up as described below 
Single reaction:  1µl   DNA (e.g. chromosome 3 or 15) 
   10µl  10x PCR buffer (No MgCl2) 
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   8µl  25mM MgCl2 
   2µl  100uM 6MW primer 
   8µl  2.5mM dNTPs 
70µl  H2O 
   1µl  Taq pol 
100µl  Total 
 
The reaction was placed in a thermocycler with the program below: 
Number of Cycles  Reaction  Temperature Time 
1    Initial denaturation 96°C  3min 
35    Denaturation  94°C  1min 
    Annealing  56°C  1min 
    Extension  72°C  2min 
1    Final extension  72°C  5min 
 
  
Next, 2μL of amplification product was run on a 1% (w/v) agarose gel with 
appropriate size markers to identify if a visible smear ranging between 
~200bp and 1.5 kb was present. If the smear was present then chromosome 
labeling with DOP-PCR was carried out.  
Chromosome labelling with DOP-PCR 
Amplification and labeling of the chromosomes was performed by setting up 
the following reaction: 
Single reaction:  2µl   DNA (e.g. chromosome 3 previously 
amplified by DOP-PCR) 
   10µl  10x PCR buffer (No MgCl2) 
   8µl  25mM MgCl2 
   2µl  100uM 6MW primer 
   5µl  2mM of ATP, GTP, CTP mix 
   8µl  1mM of TTP 
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   6µl  labelled-UTP 
58µl  H2O 
   1µl  Taq pol 
 
The reaction was placed in a thermocycler with the program below: 
Number of Cycles  Reaction  Temperature Time 
1    Initial denaturation 96°C  3min 
35    Denaturation  94°C  1min 
    Annealing  56°C  1min 
    Extension  72°C  2min 
1    Final extension  72°C  5min 
 
Finally, 2μL of the solution was checked on a 1% (w/v) agarose gel.  
 
2.3.4. Probe validation (2D FISH) 
Preperation of nuclei from newborn mouse primary fibroblasts 
Approximately 4 million cells of mouse primary fibroblasts were 
seeded into 4 Petri Dishes with complete culture medium containing FBS, 
20μg/ml of chloramphenicol and grown for 2 days.  Cells were then 
incubated for 30 min in cell culture medium containing 0.1μg/ml of colcemid 
at 37°C. After washing cells with pre-warmed 1xPBS (37°C) they were 
incubated in 2ml of trypsin (2.5g/L) for 3-5min. After cells were detached 
from substratum 4ml of medium was added. Single cells suspension was 
obtained by pipetting up and down, transferred to 15ml Falcon tubes and 
centrifuge at 200×g at RT for 6min. 80-90% of supernatant was removed 
and the cell pellet was mixed with the remaining medium.  
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Afterwards, 10ml of hypotonic 0.56% (w/v) KCl solution was added 
dropwise while the solution was being vortexed. The tube was then filled up 
to 15ml with the hypotonic solution and incubated at 37°C for 25 min. Next 
it was centrifuge at 200×g at RT for 6min and supernatant discarded.  Then 
the nuclei were resuspended in 2ml of fixative (ice cold methanol : acetic 
acid with a ratio of 1:3) and transferred to a new 15ml Falcon tube. Next, 
the tube was completely filled with fixative and centrifuged at 200×g at RT 
for 6min. Next, the supernatant was replaced with 14ml of fresh fixative 
solution, the pellet was resuspended, incubated at RT for 10min and then 
centrifuged at 200×g for 6min. This process was repeated ten times. For 
storage, the cell pellet was resuspended in 2ml of fixative solution and 
stored at -20°C.  
Metaphase spreads 
The previously prepared mouse fibroblasts were centrifuged at 250×g 
for 6min, supernatant was discarded and a new fixative consisting of 
methanol and acetic acid with a ratio of 3:1 was added. A metal tray was 
pre-heated in a water bath to 55°C after the water level was adjusted so that 
23% of air volume was left under the water bath cover. Microscopic slides 
were placed on metal tray. Two drops of mouse primary fibroblast 
suspension was applied onto each slide and left in the water bath until 
complete evaporation of the fixative. The slides were then checked under 
phase contrast microscope and if at least 3 metaphase spreads were 
observed then the slide was placed into a Coplin jar with 70% (v/v) ethanol 
and left overnight. The next day the 70% (v/v) ethanol solution was replaced 
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with a fresh 100% ethanol solution and incubated for 10min. Next, the slides 
were air dried at RT for one week in a closed container. The slides were 
then incubated for 2 hours at 60°C. Just before the end of the incubation a 
pepsin solution was prepared by adding 50μl of 10% (w/v) pepsin stock 
solution to prewarmed (37°C) 0.01M HCl. At the end of the incubation slides 
were placed into Coplin jar with pesin solution and incubate for additional 
10 min at 37°C. Slides were washed 3 times for 5 min in 1X PBS. Then 
slides were placed consequently ethanol solution, first 70% (v/v) ethanol 
and then 100% ethanol. Finally, the slides were air dried at RT and stored 
in a slide box at -20°C.  
Validation of the probe specificity and labelling efficiency 
After checking for a product expected to be present in the probe by 
PCR using specific primers, 2D FISH was carried out on the previously 
generated metaphase spreads as follows.  These components were mixed 
together in 1.5ml Eppendorf tube: 
7µl  chosen labelled chromosome (e.g. chromosome 3 or 15) 
25µl  labelled BAC probes (from 1 to 3 BACs labelled) 
10-25µl Cot1 DNA (depending on BAC’s DNA amount) 
Next, ethanol precipitation of DNA was carried out by adding 2.5 
volume of 100% ethanol and leaving the mixture at -20°C for 30-60min. The 
tubes were spun down at maximum speed for 15 min at 4°C. The 
supernatant was discarded and the pellet air dried. The pellet was then 
dissolved in 2.5 μl deionized formamide using a shaker set to 37°C for 30 
min. To complete the mounting probe, additional 2.5μl of 20% (w/v) dextran 
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sulphate in 4× SSC (Saline-Sodium Citrate Buffer, at 20× contains 3M NaCl 
in 0.3M sodium citrate at pH7.0) was added and mixed.  
The probe was then mounted onto the slide containing the highest 
density of metaphase spreads and covered with a 15x15 mm cover slip. A 
rubber cement was used to seal the cover slip. The slide was left in dark 
condition at RT for 15-20 min until the rubber cement was completely dry. 
Next the slides were incubated at 75°C for 2 min. Hybridization chamber on 
a water bath set to 37°C was used to incubate the slides for 24-48 hours.  
The cover sleep along with the rubber cement was carefully removed 
and the slides were then washed 3 times using 2xSSC for 10 min at 37°C 
and once in 0.1xSSC for 10 min at 60°C. A secondary detection system was 
assembled as follows: 
Solution: 4xSSC 
  4% (w/v) BSA 
For Bio-dUTP: Streptavidin-Cy5 (1:100)  
For Dig-dUTP: Cy3-anti-Dioixigenin (1:100) 
For FITC: anti-FITC-FITC conjugated (1:50-1:100)   
A PAP pen was used to isolate the region on the slide exposed to the 
probe. Next, 100 μl of the secondary detection system was mounted onto 
this region and left in an. Incubator for 60 min at 37°C. The slides were then 
washed in 4xSSC (0.1% (v/v) Triton) 3 times for 5 min. DAPI with a 
concentration of 0.2μg/ml (1mg/ml stock -> 5ug/ml second stock -> 0.2ug/ml 
MATERIALS AND METHODS 
80 
 
working solution) was applied to the section for 10 min. The slides were 
washed in 2xSSC for 5 min at RT. A mounting medium without DAPI was 
applied and sealed with a 0.17mm cover slip. Results were checked using 
a microscope.  
2.3.5. 3D FISH 
In a 1.5-ml tube, all the labeled DNA probes that were previously 
prepared for the hybridization were mixed together along with unlabeled 
competitor DNA, e.g., Cot-1 DNA with 5-, 10-, or 50-fold the concentration 
of probe DNA. 
To the probe DNA mixture 100% of ice cold EtOH (2.5× volumes) was 
added and kept for at least 30 min at −80°C. Then the tube was spun down 
at 15,000×g for 20 min. The supernatant discarded and the pellet air dried 
at RT. Afterwards, the pellet was resuspended in 50% (v/v) formamide/2× 
SSC/10% (w/v) dextran sulphate as follows. First, the pellet was dissolved 
in the appropriate amount (15µl) of 100% formamide and incubated at 37°C 
for 30min (vortexing every 10min). Second, an equal volume (15µl) of 4× 
SSC/20% (w/v) dextran sulphate was added to the resuspended pellet. 
Finally, the contents of the tube were briefly mixed and incubate at 37°C for 
10 min. The hybridization probe was then stored at −20°C or used 
immediately. 
The slides were removed from the -80°C and left to thaw and dry for 
30 min at RT. The fallowing optional step was performed to increase 
probe/antibody penetration in very dense tissues, permeabilize in 1× 
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PBS/0.5% (v/v) Triton X-100 at RT for 20 min. Slides were placed in a 
microwave safe Coupling jar, which was filled with 10 mM sodium citrate 
buffer (1L = 2.94g sodium citrate dissolved in distilled water, pH 6). The 
tissue was left to rehydrate in this solution for 10 min at RT. 
DNA unmasking was carried out by heating the Coupling jar container 
in a microwave oven until first signs of boiling appeared, the microwave was 
then switched off and the jar was left for 2 min at RT to cool. The jar was 
then heated again until first signs of boiling and left to cool down for 2 min 
at RT. This process was repeated 7 times. Next, the slides were transferred 
to 2× SSC. Next, the slides were equilibrated in 50% (v/v) formamide/2× 
SSC solution for at least 4 at 4°C (or stored up to 2–4 months at 4°C). 
The probe was mounted under small glass chambers specifically 
designed for DNA hybridization on relatively thick tissue sections (see Fig. 
2.1 for details). First, slides were taken out of the 50% formamide/2× SSC 
solution, excess liquid around section removed using soft paper. Next, the 
section was covered with the glass chamber and the chamber filled with the 
probe. Rubber cement was used to seal the chamber and left to dry at RT. 
The slide was prehybridized with the mounted probe at 37°C overnight 
to allow infiltration of the section with the probe. The next day the slide was 
incubated on a hot block at 80 °C for 5 min to enable simultaneous 
denaturation of cellular DNA and probe. Hybridization was carried out by 
incubating slides at 37°C in humid dark chambers (e.g, metal boxes floating 
in a water bath) for 2–3 days. Next, post-hybridization washings were 
carried after the rubber cement along with the glass chamber were carefully 
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peeled off the slide. The slide was then transferred slides to 2× SSC and 
washed 3 times for 10 min at 37°C. Final high stringency wash was carried 
out in 0.1× SSC at 60°C for 10 min. 
The detection of hybrizised regions of DNA was carried out by carrying 
out additional immunostaining for the labelled DNA. First blocking solution 
consisting of 4% (w/v) BSA and 4xSSC was applied onto the section for 15 
min. Next, antibodies tagged with fluorescent fluorophores were diluted in 
4% (w/v) BSA and 4xSSC as follows: for Bio-dUTP Streptavidin-Cy5 
(1:100); for Dig-dUTP Cy3-anti-Dioixigenin (1:100); for FITC anti-FITC-FITC 
conjugated (1:50-1:100) 
The antibody solution was then applied onto the slide and left in an 
incubator at 37°C for 60min.  The slide was then washed in 4xSSC (0.1% 
(v/v) Triton) 3 times for 5 min. DAPI with a concentration of 0.2μg/ml was 
applied to the section for 10 min. The slides were washed in 2xSSC for 5 
min at RT. A mounting medium without DAPI was applied and sealed with 
a 0.17mm cover slip. Results were checked using a microscope. 
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Figure 2.1. Schematic representation of a glass chamber used for 
hybridization. The glass chamber was prepared by cutting strips of glass 
from a coverslip using a diamond cutter and glueing them parallel on two 
borders of an intact coverslip using a nail polish. The DNA probe was 
mounted by capillary action once the glass chamber was correctly placed 
over the tissue. (Figure modified from Cremer et al., 2008) 
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2.3.6. 3D Image generation using confocal microscopy 
3D images of the tissue processed for FISH were generated using 
Confocal Laser Scanning Microscope (ZEISS, 2013). This microscope has 
a pinhole which prevents out of focus light coming from the tissue sample 
from reaching the detector. This drastically improves the contrast and 
enables to scan layer by layer through the tissue sample. These layers are 
stacked generating a Z-axis in addition to the X-axis and Y-axis. The 
information booklet from ZEISS provides more information (ZEISS, 2013).  
2.3.7. Mass Image Refining and Analysis 
To obtain useful information from the 3D FISH images a number of 
steps were performed. First, it was important to identify the XYZ-axis 
coordinates of all the BAC signals present in the nucleus. This required 
refining the images to decrease background signals and identify the specific 
signals in the image. These images were then analysed. For this, the centre 
of each specific signal within the 3D space was identified and represented 
as an XYZ coordinate. Due to the fact that up to four different lasers were 
used in generating one 3D image chromatic aberration was introduced. 
Therefore, the amount of aberration was determined by using fluorescent 
beads.  
Image Refining 
Refining of 3D images was performed through the use of a java based 
programme called ImageJ (v1.47), which was specifically designed for 
working with images (Abramoff et al., 2004) and has been used for image 
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analysis for over 25 years. By adjusting brightness and contrast as well 
using a range of build in filters, if required, it was possible to improve the 
specific signal quality. One of such filters was Gaussian Blur 3D, which uses 
a normal distribution curve to blur and thereby produce a more uniform 
distribution of the signal.  
To calculate the distance between the detected signals within a 
nucleus a Pythagoras’ theorem was used (Equation 2.1). 
Equation 2.1. Pythagoras’ equation to determine distance 
between two points 
d^2= (X1-X2)^2+(Y1-Y2)^2+(Z1-Z2)^2   
d= √d^2 
Even though the distances themselves could provide some useful 
information as they are in metric units, they by themselves are not complex. 
This is because nuclei have different volumes between themselves in one 
tissue type and even more so between different cell types. Therefore the 
distances were normalised to take this into account. Normalisation was 
carried out to the mean nuclear radius. In this case all the nuclei for which 
data was collected previously were further analysed to determine their 
average radius. This was achieved by randomly selecting at least 200 points 
throughout the whole nucleus and recording their XYZ coordinates. After 
calculatin a mean value for X, Y and Z from the 300 random points a 
hypothetical coordinate for the centre of the nucleus was obtained. Then 
distances between the 300 random points and the hypothetical centre were 
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measured using Equation 2.1. The mean value of the 300 calculated 
distances represents the mean nuclear radius, which was used for 
normalization of the distances between BACs or chromosomal territories 
(Equation 2.2).  
 
Equation 2.2. Normalised distance/% of mean nuclear radius 
Normalised distance =  distance/(mean nuclear radisu)×100 
After normalising the distances further analysis was carried out using 
R/RStudio to determine any statistical significance between different tissue 
samples. Statistical analysis was performed by identifying if data was 
normally distributed and accordingly Student t-test or Wilcoxon signed-rank 
test was used if data was parametric or non-parametric, respectively.  
Additional analysis was performed on observational data. For this 
Pearson’s Chi Squared test was used.  
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2.4. Laser Capture Microdissection and Microarray analysis 
The quick frozen samples of the skin of KrtCre-14ER/Ctcf fl/fl mice 
skin and control samples were cut using a cryostat as described above 
(Sharov et al., 2006). Skin sections of 10µm thickness were collected onto 
membrane slides (MMI, part-Nr: 50103) and stored in RNase free 
environment at -80oC overnight. These were subsequently stained 
according to the protocol supplied with the H&E RNase free kit (MMI, 
Product Nr: 70302) and epidermis was isolated into 0.5ml collection tube 
using Nikon T2000 laser capture microscope. Laser capture was performed 
for one hour to minimize RNA degradation and immediately 100µm of BL 
(lysis buffer)  and TG (1-Thioglycerol) from ReliaPrep RNA Cell Miniprep 
System Kit (Promega, Z6010) was added to the 0.5ml tube and RNA 
isolation was carried out accordingly to the supplied protocol and stored at 
-80oC. The RNA then underwent two rounds of amplification using 
Arcturus® RiboAmp® HS PLUS RNA Amplification Kit. Mouse reference 
RNA (Agilent Technologies, 750600) was also amplified and used as 
universal control during microarray analysis. All RNA samples were sent to 
Mogene Co. (USA), the company performed all the microarray analysis 
based on Mouse SurePrint G3 GE 60K whole genome microarray 
(manufactured by Agilent Technologies) as described previously (Fessing 
et al., 2011; Mardaryev et al., 2014; Sharov et al., 2006). 
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3.1. Optimization of Fluorescent In Situ Hybridization for 
Three Dimensional Imaging 
3.1.1. DNA Probe labeling   
Nick Translation (NT) was a technique used to generate labeled DNA 
probes, which were subsequently used during In Situ Hybridization as described 
in Chapter 2. During NT reaction, DNase I was used to digest large DNA fragments, 
the size of which were checked using 1% (w/v) agarose gel (Fig. 3.1). In fact, a 
perfect NT should yield a smear of DNA fragments ranging from ~300–1,000bp. 
Therefore, if further digestion was necessary (e.g. BAC RP24-68P2 in Fig. 3.1) 
another 1 µL of diluted DNase I was added for 5–10 min at 20°C and the resulting 
DNA fragment size was checked again on an agarose gel (Fig. 3.1). Once optimal 
NT products were obtained the probe was generated as described in previous 
chapter.     
3.1.2. Utilization of computation tools for automation of 3D FISH 
analysis 
To automate the detection of all the signals within the nuclei of the 3D 
images an imageJ plugin, Object Counter 3D, was used to facilitate this 
process.  Object Counter 3D measured the pixel density of the signals in 
the image stack, locate the geometric centre of the signal and produce a file 
with a list of XYZ values (Fig. 3.2). Also, each coordinate was tagged with 
a unique ID number, which was also plotted next to the signal on the image. 
This enabled visual identification of the signals of interest and the retrieval 
of their XYZ values (Fig. 3.2) using programming language R. (Bolte and 
Cordelieres, 2006).  
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3.1.3. Compensating for chromatic shift aberration during 3D FISH 
Analysis.  
All the ID numbers present next to specific signals within the nuclei 
of interest were recorded and their XYZ coordinates retrieved using a script 
written in R/RStudio. The XYZ values were then adjusted for the chromatic 
shift. This process was accomplished by scanning 0.5 μm fluorescent 
beads. The LSM microscope had four lasers and four filters and therefore 
could excite and detect 4 channels with the light wavelength of 360 
(excitation)/460nm (emission) (DAPI), 495/520nm (FITC), 550/570nm (Cy3) 
and 650/670nm (Cy5). The fluorescent beads were able to emit light at all 
of the excitation wavelength and enable the observation of the shift of each 
channel (Fig. 3.3). The mean chromatic shift in the X,Y and Z direction for 
each channel in relation to the reference channel, which was selected to be 
DAPI (channel 1), was determined from approximately 20 beads. The X,Y 
and Z values of the BAC signals determined previously were adjusted using 
these mean values. Chromatic shift was measured on a regular basis 
especially after any calibrations or servicing were carried out on the 
microscope. 
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Figure 3.1. Example of the labelled BAC probes after Nick Translation. 
The BAC called RP24-68P2 was digested further to produce DNA 
fragments of the desired length as shown in the right image.  
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Figure 3.2. The process of refining 3D FISH images and obtaining 
signal coordinates for labelled BACs using ImageJ. Before and after 
images are shown after refining them and obtaining coordinates of each 
signal using Object Counter 3D plugin.  The plugin also generates a 
separate file with the coordinates of all the signals for each fluorescent 
channel file tagged by a number that is also plotted on an image.  
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Figure 3.3. Representation of chromatic shift obtained by LSM using 
0.5 μm fluorescent beads. The merged image of four different channels 
shows that they do not completely overlap with each other. 
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3.2. Analysis of higher order chromatin organisation in the 
epidermis of genetically engineered mice with ablation of 
the Keratin type 2 locus 
During development, the genome of multi-potent stem cells becomes 
reorganized in 3D nuclear space to establish a proper spatio-temporal 
regulation of transcription underlying execution of lineage-specific gene 
expression programs (Bickmore and van Steensel, 2013; Dekker et al., 
2013; Schoenfelder et al., 2010a; Wei et al., 2013). However, mechanisms 
coordinating transcription in lineage-specific gene loci located on different 
chromosomes during cell differentiation are poorly understood. 
Differentiation of the epidermis is accompanied by tightly-balanced 
expression of the keratinocyte-specific genes that are clustered in the 
mammalian genome into several loci including the Keratin type I (KtyI) and 
type II (KtyII) gene loci located on mouse chromosomes 11 and 15, 
respectively, as well as the Epidermal Differentiation Complex (EDC) locus 
located on mouse chromosome 3 (Blanpain and Fuchs, 2009; Koster and 
Roop, 2007; Watt and Huck, 2013). Chromosomal conformation capture 
techniques, such as 3C, 4C and 5C, have shown that genes tend to form 
inter- and intra-chromosomal interactomes required for establishment of 
lineage-specific gene expression programs (Schoenfelder et al., 2010b).  
Data obtained from Prof. Thomas Magin’s laboratory (University of 
Leipzig, Germany) revealed that genetically engineered mice with ablation 
of Keratin type II locus from chromosomes 15 display severe epidermal 
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barrier defects (Kumar et al., 2015). Epidermis of KtytII-/- showed a compact 
alterations in expression of 37 genes in the EDC locus and apparent 
absence of filaggrin and locricrin-positive keratohyalin granules, compared 
to controls (Kumar et al., 2015). Global gene expression analysis of back 
skin RNA from KtyII-/- and control littermates at E18.5 showed that of the 
61 genes located on the EDC (de Guzman Strong et al., 2010), 15 encoding 
structural CE components, among them loricrin, filaggrin 2, hornerin (Hrnr) 
and late cornified envelope group 1 (Lce1) genes, were strongly 
downregulated in KtyII-/- mouse skin. However, 22 genes including small 
proline-rich genes (Sprrs), S100A8 and late cornified envelope group 3 
(Lce3) genes, connected to oxidative stress, barrier defects and 
hyperproliferative skin conditions, were upregulated upon Keratin type II 
locus ablation (Kumar et al., 2015).   
To better understand the topological relationships between the EDC 
and Keratin type II loci in the nucleus, the 3D-FISH analyses of the nuclear 
positioning of these loci was performed in epidermal keratinocytes of WT 
mice and genetically engineered mice with ablation of KtyII locus obtained 
from Magin’s lab, as well as in thymocytes (selected as the control), in which 
gene expression in both loci is markedly decreased compared to 
keratinocytes. Because nuclear morphology in the epidermal keratinocytes 
is markedly changed during cell transition from the basal to granular layer 
(Gdula et al., 2013), only nuclei of non-proliferating basal epidermal 
keratinocytes containing diploid number of genomic loci were selected for 
3D-FISH analyses.    
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3.2.1. 3D FISH analysis of keratinocyte-specific gene loci in epidermal 
keratinocytes of wild-type mice and thymocytes 
For 3D-FISH analyses, distinct DNA probes were generated from BAC 
clones covering the entire EDC or KtyII loci, as well as the genes that 
constitute as components of these loci (Lor and Krt5, respectively), or 
located in the immediate vicinity to either 3’- or 5’- ends of the KtyII locus 
(Ankrd33, Eif4b) (Table 2.3). In addition, positioning of the EDC and KtyII 
loci was assessed relative to the corresponding chromosome territories 3 
and 15, as described previously (Fessing et al., 2011; Mardaryev et al., 
2014).  
The analysis of the 3D FISH data determined that the chromosomal 
region containing Loricrin gene is found closer to the keratin type 2 locus in 
epidermal keratinocytes than in thymocytes. This conclusion is based on 
the shorter distances observed between Loricrin and Keratin Type 2 locus 
in epidermal keratinocytes than in thymocytes (Fig. 3.4.a). Further statistical 
analysis determined that a statistically significant difference was present 
within the actual distances (Fig. 3.4.b). As the size of the nuclei varies within 
a specific tissue and between different cell types, as measured with mean 
nuclear radius (Fig. 3.4.c), the distances were normalised to the mean 
nuclear radius. The normalised distances were also significant (Fig. 3.4.d).  
The position of chromosomes themselves in different tissue types 
might be different thereby contributing to the previous results. In both cell 
types, chromosome 3 was always located more peripherally in the nucleus 
compared to the chromosome 15, which was located more centrally. Both 
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chromosomal territories (3 and 15) showed quite close localization in 
keratinocytes and thymocytes, and the distances between the centres of 
chromosomal territories 3 and 15 were analysed (Fig. 3.5.a).  It was 
determined that the mean distance between centres of the Ch3 and Ch15 
was shorter in thymocytes (Fig. 3.5.c) after normalization of the raw data 
(Fig. 3.5.b).  Therefore, chromosomal location was eliminated as a factor to 
explain the longer distances observed between Lor and Keratin Type II 
locus in thymocytes.  
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Figure 3.4. Lor shows closer positioning to the Kty2 locus in epidermal 
keratinocytes (KC) compared to thymocytes (TC).  (a) Multicolour 3D 
FISH with BACs depicting Lor and KtyII locus in epidermal keratinocytes 
and thymocytes with arrows indicating the location of the detected signals.  
(b) Distribution of distances between Lor and KtyII locus in µm (Wilcoxon 
test, **p<0.01, n=120 from 30 nuclei, box and whisker distribution).  (c) 
mean radius of each nucleus from epidermal keratinocytes and thymocytes 
(t-test, ***p<0.001, n=30 nuclei). (d) Distribution of distances normalised to 
mean nuclear radius between Lor and KtyII locus (Wilcoxon test, **p<0.01, 
n=120 from 30 nuclei, box and whisker distribution). 
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Figure 3.5. Distances between centres of the chromosomal territories 
3 and 15 are shorter in thymocytes (TC) compared to epidermal 
keratinocytes (KC). (a) Multicolour 3D FISH with arrows indicating the 
localisation of chromosomal territories 3 and 15. (b) Distribution of distances 
between Ch3 and Ch15 in µm. Analysis performed on 84 loci obtained from 
21 KC nuclei versus 120 loci obtained from TC nuclei (Wilcoxon test, 
p<0.01). (c) Distribution of distances normalised to mean nuclear radius 
between Ch3 and Ch15 (Wilcoxon test, p<0.05). 
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3.2.2. 3D FISH analysis of keratinocyte-specific gene loci in epidermal 
keratinocytes of wild type mice and keratin type 2 locus knock out 
mice  
Firstly, KtyII ablation in the KtyII knockouts was confirmed by 
determining if the distances between the 3’- and 5’-flanking regions of the 
KtyII locus were shorter in KtyII locus KO mice as compared to WT 
epidermis (Fig. 3.6.a). Statistical analysis of the distances between the 
flanking regions of the KtyII locus after normalising to the mean nuclear 
radius (Fig. 3.6.c) showed significant differences between WT and KtyII 
locus KO mice (Fig. 3.6.d), thus documenting the ablation of the KtyII locus 
at the 3D nuclear organization levels.  
Also, our 3D-FISH analyses revealed that in contrast to basal 
epidermal keratinocytes of WT mice, a significant repositioning of the Lor 
gene away from the genes that constitute 3‘ or 5‘ ends of the KtyII locus 
occurred in KtyII locus-deficient mice. The distances between the Lor and 
the KtyII locus flanking regions in epidermal keratinocytes of WT mice were 
significantly shorter compared to KtyII locus KO mice (Fig. 3.7.b,c). The 
reposition of the Lor gene away from the KtyII locus flanking regions was 
accompanied by significant changes in the positioning of the Lor gene 
relative to the chromosomal territory 3 (from internal to peripheral), 
suggesting a marked remodeling of the higher-order chromatin structure in 
the EDC locus upon KtyII locus ablation (Fig. 3.9). 
However, the distances between centres of chromosomal territories 3 
and 15 (Fig. 3.8) were unchanged in KtyII locus KO mice versus WT 
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controls, suggesting that the positioning of the chromosomal territories 3 
and 15 was unchanged upon the KtyII locus ablation. Interestingly, 
epidermal keratinocytes in KtyII locus KO mice showed less frequent 
associations of the EDC locus and flanking regions of the KtyII locus with 
SC35-positive nuclear speckles (Fig. 3.10). Because nuclear speckles and 
the associated proteins/RNAs are involved in facilitating the transcription of 
lineage-specific genes (Spector and Lamond, 2011), relocation of the EDC 
locus away from the nuclear compartment enriched by nuclear speckles 
might explain alterations in expression of the EDC genes in KtyII locus KO 
mice.  
Thus, ablation of the KtyII locus result in the remodeling of the higher-
order chromatin structure of the EDC locus and its neighboring regions on 
chromosome 3. Because KtyII locus ablation results in marked changes in 
the EDC gene expression (Kumar et al., 2015), these data also suggest that 
KtyII locus might contain specific enhancers for the EDC genes, which might 
physically interact with the EDC gene promoters and facilitate their 
expression in epidermal keratinocytes of WT mice. 
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Figure 3.6. Distance between flanking regions of the Keratin Type 2 
locus (KtyII) is shorter in epidermal keratinocytes of KtyII locus knock 
out mice compared to wild-type mice. (a) Multicolour 3D FISH with BACs 
depicting 5’ and 3’ flanking regions of KtyII locus in wild type and KtyII KO 
epidermal keratinocytes (P8) and with arrows indicating the location of the 
detected signals. (b) Distribution of distances between 5’ and 3’ of KtyII 
locus in µm. (c) mean radius of nuclei from Wild Type and KtyII KO 
epidermal keratinocytes (t-test, ***p<0.001, n=120 from 60 nuclei). d- 
Distribution of distances normalised to mean nuclear radius between 5’ and 
3’ of KtyII locus (Wilcoxon test, **p<0.01, n=120 from 60 nuclei, box and 
whisker distribution). 
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Figure 3.7. Loricrin gene is localized in the vicinity of the KtyII locus in 
keratinocytes, while KtyII locus ablation results in the Lor 
repositioning away from the KtytII locus flanking regions. (a) 
Multicolour 3D FISH with BACs depicting Lor, 5’ and 3’ flanking regions of 
KtyII locus in wild type and KtyII KO epidermal keratinocytes with arrows 
indicating the location of the detected signals. (b) Distribution of distances 
between Rps27 and KtyII locus in µm. (c) Distribution of distances 
normalised to mean nuclear radius between Rps27 and KtyII locus 
(Wilcoxon test, **p<0.01, 120 loci from 30 nuclei, box and whisker 
distributions). 
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Figure 3.8. Distances between the centres of chromosomal territories 
3 and 15 are unchanged in epidermal keratinocytes of WT and KtyII KO 
mice. (a) Multicolour 3D FISH with arrows indicating the localisation of 
chromosomal territories (CT) 3 (purple) and 15 (green) in epidermal 
keratinocytes. (b) Distribution of the distances between CT3, CT15 in µm. 
Analysis was performed based on data from 84 loci obtained from 21 WT 
nuclei and 108 loci obtained from 27 KtyII-/- nuclei, data represented as box 
and whisker distribution (***p<0.001). (c)  Normalised to mean nuclear 
radius distribution of the distances between CT3 and CT15, no significance.  
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Figure 3.9. Lor positions within the Chromosome Territory 3 change 
from the internal to peripheral in epidermal keratinocytes of KtyII locus 
knockout mice. (a) Multicolour 3D FISH with arrows indicating the 
localisation of Lor (green) within Chromosome Territory 3 (CT3) (red) 
relative to the nucleus (DAPI), Scale = 2µm. (b) Analysis of Lor position 
within CT3, data obtained by analysing 35 nuclei (70 loci) of WT and 35 
nuclei (70 loci) of KtyII-/-  image stacks, the location of each Lor loci within 
the CT3 was assigned to Peripheral (P), Median (M) or Internal (I). WT = 
14(P), 37(M) and 19(I); KtyII-/- = 30(P), 29(M), 11(I). Analysis was 
performed using Pearson’s Chi-Squared test (p=0.012). 
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Figure 3.10. Localization of the EDC, Keratin Type 2 locus and SC35+ 
speckles in the nucleus. (a) 3D-FISH for EDC and KtyII locus combined 
with immunostaining for SC35 (Speckles), arrows show co-localization of 
EDC, KtyII and Speckle. Scale = 2µm. (b) Analysis of number of cells 
showing co-localization of EDC, KtyII genomic loci and speckles, shown as 
a percentage (WT = 14 out of 26 total nuclei analysed showed co-
localization between EDC, KtyII and Speckles; KtyII-/- = 5 out of 25 total 
nuclei analysed showed co-localization between EDC, KtyII-/-(flanks) and 
Speckles; Analysis was performed using Pearson’s Chi-Squared Test).  
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3.3. Analysis of Ctcf expression during skin 
morphogenesis 
Ctcf gene is a member of a special class of chromatin architectural proteins 
important for organizing 3D chromatin structure and enhancer-promoter 
interactions (Ohlsson et al., 2010). Even though Ctcf is one of the best 
characterized chromatin remodeling genes, its role in the control of skin 
development has not been previously demonstrated. 
Immunohistochemistry using anti-Ctcf antibody was carried out on the skin 
of wild-type mice in order to elucidate the expression of this protein during 
skin development, postnatal growth and hair follicle cycling (Fig. 3.11 and 
Fig. 3.12).  
3.3.1 Ctcf expression in the skin during embryogenesis 
At embryonic day (E14.5), when basal layer and intermediate layer are 
present in skin epithelium, the Ctcf expression was observed in all nuclei of 
the epidermal and dermal cells (Fig. 3.11.a). By E16.5, when granular layer 
is established, the levels of Ctcf expression had increased in the epidermis. 
Furthermore, early hair follicle placodes became positive for Ctcf, which 
expression was also seen in the mesenchymal cells beneath the epithelial 
placodes (Fig. 3.11.b). At E18.5, when cornified layer is formed, the Ctcf 
expression was strongest in the basal layers of the epidermis and papillary 
layer of the dermis (Fig. 3.11.c). Furthermore, the hair follicle at later stages 
of development showed higher levels of Ctcf expression in both epithelium 
and mesenchyme (e.g. in stage 5 hair follicle shown in Fig. 3.11.c).    
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3.3.2. Ctcf expression in the skin during postnatal development  
At day 1.5 after birth (P1.5) Ctcf expression remained strong in the 
epidermis and the dermis. Levels of Ctcf were strongest in the bulb of 
developing hair follicles (Fig. 3.11.d). Similar pattern of expression was 
observed at P3.5. Furthermore, strong Ctcf expression was observed in the 
hair follicle infundibulum, outer root sheath and interfollicular epidermis, 
while lower levels of Ctcf were visible in the inner root sheath (Fig. 3.11.e). 
At P10.5 and P17.5, the cells of the basal layer remained positive for Ctcf 
(Fig. 3.11.f,g). However, in hair follicles during catagen (Fig. 3.11.g) the 
levels of Ctcf in the shrinking hair bulb and outer root sheath remained high 
(Fig. 3.11.g). At P25.5, when the hair follicles progressed through catagen, 
telogen and entered new anagen, the Ctcf expression remained strong 
including the hair follicle epithelium and the derma papilla (Fig. 3.11.h).    
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Figure 3.11. Expression of Ctcf in normal skin during mouse 
development. Immunihistochemistry performed on mouse skin at different 
developmental time-points during embryogenesis and after birth. 
Embryogenesis (E) stages shown are E14.5 (a), E16.5 (b) and E18.5(c). 
Post-natal developmental stages are P1.5 (d), P3.5 (e), P10.5 (f), P17.5 (g) 
and P25.5 (h). Arrows point towards the following structures: IFE – 
interfollicular epidermis, IRS – inner root sheath, ORS – outer root sheath, 
Bulb, DP – dermal papilla, Inf -  infundibulum. Scale bar = 100µm.  
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Figure 3.11. For Legend See Facing Page 
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3.3.3. Ctcf expression in the skin during postnatal hair follicle cycling 
To further understand how Ctcf expression levels change during hair follicle 
cycling, wild-type 8 week-old mice were depilated and skin was harvested 
at different days after the procedure. Immunohistochemistry for Ctcf 
expression was performed on these samples. The results showed that Ctcf 
was present in the cells of the telogen skin of un-depilated mice (Fig. 
3.12.a). Interestingly, the levels of Ctcf in the anagen I hair follicles of day 3 
p.d. (day 3 post depilation) appeared to be higher than in telogen (Fig. 
3.12.b). At day 5 p.d., when hair follicles are in anagen IV, Ctcf expression 
was high in the bulb and dermal papilla (Fig. 3.12.c). On day 12 p.d., when 
hair follicles were in late anagen, the Ctcf expression was very strong in the 
bulb and dermal papilla. During catagen, expression of Ctcf in the outer root 
sheath remained high. Interestingly, transition from early catagen (day 16 
p.d.) to late catagen state (day 19 p.d.) associated with the hair bulb 
shrinkage was also accompanied with decrease in Ctcf expression (Fig. 
3.12.d,e). However, the hair follicles at day 21 p.d. (telogen) showed high 
levels of Ctcf expression. 
The epidermis also showed high levels of Ctcf expression during hair follicle 
cycling. At day 3 p.d., when the epidermis became thicker, the Ctcf 
expression was seen in both basal and suprabasal keratinocytes (Fig. 
3.12.b). Levels of Ctcf in the epidermis appeared to be high through anagen 
and early catagen (Fig. 3.12.c,d,e,f). At day 21 p.d., the Ctcf levels in the 
epidermis appeared to decrease (Fig. 3.12.g).  
RESULTS 
112 
 
 
Figure 3.12. Expression of Ctcf in mouse skin during induced hair 
cycle. Immunohistochemistry for Ctcf was carried out on skin samples 
harvested from adult mice at different time points after induction of a hair 
cycle. The time points correspond to the distinct hair cycle stages: Telogen 
(a,g), Anagen at days 3 p.d (b), 5 p.d. (c) and 12 p.d (d) and Catagen at 
days 16 p.d. (e) and 19 p.d. (f). Scale bar = 100µm.  
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3.4. Analysis of skin development and keratinocyte 
differentiation in the epidermis in genetically-engineered 
mice with Keratin-14 driven Ctcf ablation 
The functional importance of Ctcf in establishing organ development 
and cell fate decisions is demonstrated by the fact that Ctcf-null mice die 
early during embryogenesis (Moore et al., 2012). To study the role of Ctcf 
in the control of skin development, a genetically modified mice with a 
conditional knock out of Ctcf only in the skin epithelial cells have been 
generated. Specifically, previously created Ctcf fl/fl mice (described by 
Heath et al. 2008) were crossed with a mouse strain expressing the 
tamoxifen-inducible Cre-recombinase under the control of cytokeratin 14 
promoter (Krt14-CreER), which is specific to the basal layer of the epidermis 
and the hair follicle outer root sheath (Koster and Roop, 2007). Upon 
addition of tamoxifen, Ctcf is ablated from the genome by the Cre-
recombinase in the Keratin-14 expressing cells.  
To study the role of Ctcf in the control of skin of development, time-
mated K14-CreER/Ctcf fl/fl mice were intraperitoneally injected with 
tamoxifen at E12.5 for three days and embryos were collected at E16.5 and 
E18.5. Immunohistochemistry using anti-Ctcf antibody showed a 
downregulation of Ctcf protein in the tamoxifen treated cells, indicating that 
Ctcf gene had been indeed ablated in keratinocytes (Fig. 3.13.a). However, 
Ctcf protein was seen in the skin mesenchymal cells of both K14-
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CreER/Ctcf fl/fl and WT mice, indicating for the specific Ctcf ablation in the 
basal epidermal cells induced by tamoxifen (Fig. 3.13.a). 
In skin cryosections stained for alkaline phosphatase at E16.5 (Fig. 
3.13.b) and E18.5 (Fig. 3.13.c), a significant increase in the epidermal 
thickness was seen upon Ctcf ablation compared to WT controls (Fig. 
3.13.d,e). Furthermore, analysis of hair follicle development in E18.5 
embryos showed a significant retardation of their development in Ctcf-
deficient skin compared to controls (Fig. 3.13.f). However, the number of 
hair follicles was not significantly different (number of hair follicles per mm 
of epidermal length: Ctcf_KO=10, WT=12, p=0.50).  
To determine if the differences in epidermal thickness were due to 
an increase of proliferation in the Ctcf-deficient keratinocytes 
immunohistochemistry for proliferation marker Ki67 was carried out. 
Interestingly, Ctcf-deficient epidermis showed ectopic presence of Ki67 
positive cells in the suprabasal layer of the epidermis, while in WT controls 
Ki67-positive cells were only seen in the basal epidermal layer (Fig. 3.14.a). 
Also, the number of cells positive for Ki67 in the basal layer was significantly 
higher in the Ctcf-deficient epidermis of both E16.5 and E18.5 skin samples 
than in the corresponding controls (Fig. 3.14.b).  
To identify if Ctcf ablation had an effect on the keratinocyte 
differentiation, immunostaining was carried out against key differentiation 
markers (cytokeratin 14, cytokeratin 10 and Loricrin) on E16.5 embryos. 
Fluorescent microscopy showed that in addition to basal epidermal layer, 
cytokeratin 14 expression was ectopically seen in the suprabasal layer of 
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Ctcf-deficient epidermis (Fig. 3.15). Furthermore, Krt10 expression was 
expanded in the Ctcf-deficient epidermis as compared to control (Fig. 3.15). 
Finally, a weaker expression of Loricrin, the marker of terminally 
differentiating keratinocytes was seen in Ctcf-deficient epidermis as 
compared to controls (Fig. 3.15).  
Thus, Ctcf ablation in the epidermal keratinocytes during skin 
development results in increased epidermal proliferation and thickness, as 
well as in alterations of terminal keratinocyte differentiation and retardation 
of hair follicle development.  
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Figure 3.13. Development of the epidermis and hair follicles in Ctcf 
deficient mice. (a) Immunohistochemistry against Ctcf in the 
Krt14CreER/Ctcf fl/fl embryos treated with tamoxifen (Ctcf-/-) and DMSO 
treated control mice, scale bar = 100µm. (b) Staining for alkaline 
phosphatase (AP) in E16.5 DMSO treated (WT) and tamoxifen-treated 
(Ctcf-/-) embryos, scale bar = 25µm. (c) Staining for AP in E18.5 DMSO 
treated (WT) and tamoxifen-treated (Ctcf-/-) embryos, scale bar = 100µm. 
(d) Mean thickness of dorsal skin was determined from two Ctcf-deficient 
embryos and two WT embryos at E18.5 as follows. For each embryo five 
images were taken of the different areas of the dorsal skin and thickness 
randomly measured. These technical replicates were averaged for each 
animal. The mean was then calculated for two animals per treatment group.  
Student t-test was used to compare the means. (e) Analysis was carried out 
as described in d for E16.5. (f) Percentage of the mean number of hair 
follicles at different stages of development in E18.5. Analysis was performed 
from two Ctcf-deficient embryos and two control embryos. For each embryo 
five images were taken of the dorsal skin. All hair follicles in the images were 
counted and each hair follicle was assigned to most appropriate stage of 
development (1-5). Then, number of hair follicles per stage was determined, 
converted to percentage, and a mean calculated between two embryos per 
group. Student t-test was carried out to compare the means of each stage 
(*P < 0.05, ** P < 0.01).  
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Figure 3.13. For Legend See Facing Page 
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Figure 3.14. Cell proliferation analysis in the epidermis of Ctcf- 
deficient and control mice. (A) Immunostaining for proliferation marker 
Ki67 in DMSO- (WT) and tamoxifen-treated (Ctcf-/-) E16.5 embryos. (B) 
Analysis of Ki67-positive cells in basal layer of Ctcf-deficient epidermis vs 
controls based on mean value obtained from two animals (E16.5 and 
E18.5). Student t-test was used to compare the means * P < 0.05.  
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Figure 3.15. Expression of keratinocyte differentiation markers in the 
epidermis of Ctcf-deficient and control mice. Immunohistochemistry for 
the markers of keratinocyte differentiation (Krt14, Krt10, Loricrin) in the 
epidermis of Krt14CerER/Ctcf fl/fl and control mice. Expansion of the Krt14 
and Krt10 in the epidermis upon Ctcf ablation. Scale bar = 100µm.  
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3.5. Analysis of keratinocyte differentiation in the adult 
epidermis of genetically engineered mice with ablation of 
the chromatin architectural protein Ctcf 
Because embryonic skin development was altered in Ctcf mutant 
embryos, it was logical to obtain complementary results from postnatal skin. 
However, we have not been able to obtain any early postnatal skin samples 
from Krt14-CreER/Ctcf fl/fl mice, possibly due to their lethality during the last 
day of pregnancy or during delivery. To study the role of Ctcf in the control 
of homeostasis in adult skin, 8 week-old Krt14-CreER/Ctcf fl/fl mice were 
injected and topically treated with tamoxifen for three days and their skin 
was harvested at days 5, 7, 9 and 12 after the start of treatment. Validation 
of Ctcf ablation was carried out by immunostaining for Ctcf and genotyping 
of mice. The results confirmed that the expression of Ctcf in the epidermis 
was markedly reduced in the tamoxifen-treated mice (Fig. 3.16) and 
deletion product was seen by PCR (Fig. 3.16.b) in the epidermis of treated 
day 7 skin as compared to control. 
3.4.1 Microscopic analyses of the epidermal phenotype in adult Ctcf-
deficient mice 
The striking increase of epidermal thickness was seen in the skin of  
Krt14-CreER/Ctcf fl/fl mice compared to controls (Fig. 3.17.a-d) at days 7, 
9 and 12 after tamoxifen treatment (Fig. 3.17.e). Surprisingly, the highest 
increase in the epidermal thickness was seen at day 7 after beginning of the 
experiment. Furthermore, toluidine blue staining showed increased 
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penetration of the dye in the Ctcf-deficient skin confirming that the epidermal 
barrier function is compromised in knock-out mice (Fig. 3.17.f).   
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Figure 3.16. Ctcf expression in tamoxifen-treated skin of Krt14-
CreER/Ctcf fl/fl mice. (a) Immunostaining for Ctcf on day 7 after tamoxifen 
treatment. (b) Genotyping for Ctcf deletion in tamoxifen-treated and 
untreated skin. PCR products cluster in the regions 400-500bp. Arrow 
indicated the deleted Ctcf product.  
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Figure 3.17. Skin phenotype of adult Ctcf-deficient mice. Skin sections 
at different days after tamoxifen or DMSO treatment were stained for H&AP. 
(a) 5 days after treatment, (b) 7 days after treatment, (c) 9 days after 
treatment, (d) 12 days after treatment, scale = 100µm. (e) Analysis of 
epidermal thickness of skin samples obtained from Ctcf-deficient and 
control mice at distinct time-points after tamoxifen treatment, day 7 after 
treatment shows the mean epidermal length from three animals for control 
and three animals from tamoxifen treatment, these were used for Student t-
test analysis, the time points for day5, day9 and day 12 after treatment are 
average epidermal thickness from one animal only. (f) Toluidine blue 
demonstrate retention of the dye in the epidermis of Ctcf-deficient mice 
documenting alterations of the epidermal barrier. Lack of the dye 
penetration through the epidermis is seen in the control mice. 
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3.5.2 Expression of markers for cell proliferation and epidermal 
differentiation in the skin of Ctcf-deficient mice 
Immunostaining for proliferation marker Ki67 showed significantly 
increased number of proliferating cells in the basal layer of the epidermis in 
tamoxifen treated Ctcf-deficient mice compared to controls (Fig. 3.18.a,b). 
Furthermore, some Ki67 positive cells were detected in the suprabasal layer 
(Fig. 3.18.a, arrows) of Ctcf-deficent epidermis, while such cells were 
exclusively seen in the basal epidermal layer of control mice.  
Immunostaining for the markers of epidermal differentiation revealed 
expansion of the Krt14 expression in the epidermis of tamoxifen-treated 
mice, however, signal intensity of this marker was lower in both the 
epidermis and hair follicles than in controls (Fig. 3.19.a). Expression of 
cytokeratin 10 was expanded in the Ctcf-deficient epidermis (Fig. 3.19.b) 
and appeared to overlap with the expression of Krt14 (Fig. 3.19.a,b). 
Furthermore, ectopic Krt10 expression was seen in the upper portions of 
the hair follicle, specifically, in the infundibulum and possibly upper part of 
the outer root sheath (Fig. 3.19.b). Loricrin showed patchy expression in 
the Ctcf-deficient epidermis (Fig. 3.19.c). Surprisingly, un-identified DAPI 
positive cells were detected above the cornified layer of the epidermis and 
were located close to or directly above the hair follicle (Fig. 3.19.c). The 
effects of Ctcf ablation on hair follicle cycling were not investigated in detail 
and will be investigated further in the future.   
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3.5.3. 3D-FISH analysis of keratinocyte-specific gene loci in the 
epidermis of wild-type mice and Ctcf knock-out mice  
Because the EDC and KtyII loci harbouring lineage-specific genes 
activated during keratinocyte differentiation showed close associations 
between each other and nuclear speckles in the nucleus (Fig. 3.6, 3.7, 3.9), 
3D-FISH analyses of the nuclear positioning of the EDC and KtyII loci was 
performed on the epidermis of 8 week-old K14-CreER/Ctcf fl/fl mice treated 
with tamoxifen and corresponding control mice. 3D-FISH analyses revealed 
that in contrast to basal epidermal keratinocytes of control mice, a significant 
repositioning of the EDC locus away from the KtyII locus occurred in Ctcf-
deficient mice. The distances between the EDC and the KtyII loci for 
epidermal keratinocytes of control mice were significantly shorter compared 
to Ctcf-deficient mice (Fig. 3.20). These data suggest that Ctcf might be 
involved in mediating the cross-talk between the EDC and KtyII loci in the 
nucleus, perhaps, via regulation of the higher-order chromatin remodelling 
and chromatin looping in the corresponding genomic domains on 
chromosomes 3 and 15, respectively. 
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Figure 3.18. Analyses of cell proliferation and apoptosis in the 
epidermis of Ctcf-deficient mice. (a) Immunofluorescence of proliferation 
marker Ki67 in Ctcf-deficient epidermis, arrows indicate Ki67+ve cells in the 
subprabasal layer. Scale bar = 100µm.  (b) Analysis of the number of Ki67+ 
cells in basal layer, represented as mean percentage of total cells obtained 
from two animals, significance calculated using Student t-test. (c)  TUNEL 
staining for apoptotic cells in day 7 p.t. (post treatment) and control. (d)  
Mean intensity of TUNEL fluorescence in the epidermis calculated from two 
control animals and two treated animals measured using ImageJ, P value 
calculated using Student t-test. 
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Figure 3.18. For Legend See Facing Page 
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Figure 3.19. Expression of keratinocyte differentiation markers in Ctcf- 
deficient epidermis. (a) Immunofluorescence of epidermal differentiation 
marker of basal layer - cytokeratin 14. (b) Immunofluorescence of epidermal 
differentiation marker of suprabasal layer - cytokeratin 10. Expansion of 
cytokeratin 10 into the hair follicle infundibulum. (c) Immunofluorescence of 
epidermal differentiation marker of the granular/cornified layers – loricrin. 
Scale bar = 100µm.   
RESULTS 
129 
 
 
Figure 3.20. Distances between the EDC and Keratin Type 2 loci in the 
nuclei of basal epidermal keratinocyte of Ctcf-deficient mice. (a) 3D 
FISH for EDC (green) and KtyII locus (red) in 8 week old epidermal 
keratinocytes of day 7 p.t.  and C57Bl6 (WT) mice, scale bar = 2µm. (b) 
Analysis of shortest distance between EDC and KtyII loci per nucleus from 
WT (35 nuclei) and Ctcf-deficient epidermis (30 nuclei) and normalized to 
mean nuclear radius, data represented in box-whisker plot and p-value 
calculated using Wilcoxon test.   
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3.5.4. Increased number of immune cells in the Ctcf-deficient skin 
A defective epidermal barrier should result in an increased immune 
response and inflammation due to penetration of the microorganisms 
through the cornified layer. To show that this is the case, 
immunofluorescence was carried out for immune T cell markers CD3, CD4 
and CD8, as described previously (Mardaryev et al., 2011). The results 
showed markedly increased number of CD3+ cells in the epidermis and 
dermis of Ctcf-deficient mice compared to controls (Fig. 3.21.a,d). Similar, 
pattern was seen for CD4+ cells (Fig. 3.21.b,d) and CD8+ cells (Fig. 
3.21.c,d). These data demonstrate that skin of Ctcf-deficient mice is 
characterized by the epidermal and dermal inflammatory response, most 
likely due to the alterations of the epidermal barrier followed by the influx of 
harmful micro-organisms and activation of anti-inflammatory genes.   
3.5.5. Expression of epidermal markers is detected in the hair 
follicles of tamoxifen treated K14-CreER/Ctcf-floxed mice.   
 Interestingly, a few K14-CreER/Ctcf-floxed samples which were 
treated with tamoxifen, showed abnormal expression of epidermal markers 
in the hair follicles. For an unknown reason, time-mated mice treated with 
tamoxifen for three days before expected day of delivery consistently did 
not produce viable pups. However, by chance some dead pups were found, 
which upon immunohistochemistry showed a great decrease in the number 
of hair follicles (not analyzed), and the hair follicles that were present where 
greatly reduced in size and showed expression of Keratin 10 and Loricrin 
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(Fig. 3.22.a). Staining for Lhx2 hair follicle stem cell marker showed some 
positive cells still present at the bottom part of the hair follicles (arrows, Fig. 
3.22.a).  
During another experiment, which involved tamoxifen treatment of 8-
week-old K14-CreER/Ctcf-floxed mice for three days by Intraperitoneal 
injection followed by depilation, aberrant expression of K10 was seen in the 
hair follicles. Specifically, part of the skin from day 5 post depilation sample 
showed K10 expression in both epidermis and the hair follicles, while, 
control samples only showed K10 expression in the epidermis as expected. 
Both experiments independently verify that levels of Ctcf expression in the 
hair follicle stem cells might play an important role in regulating their fate.  
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Figure 3.21. Analyses of expression of the immune cell markers in the 
epidermis of Ctcf-deficient skin. (a) Immunofluorescence for T-cell 
markers CD3, (b) CD4 and (c) CD8 in the skin of Ctcf-deficient mice versus 
the controls. Scale bar = 100µm. (d) Mean number of cells per mm length 
of epidermis from two Ctcf-deficient animals and two WT animals. Student 
t-test was used to compare means.   
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Figure 3.21. For Legend See Facing Page 
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Figure 3.22. Epidermis specific genes are expressed in the hair 
follicles of Ctcf-deficient mice. (a) Pregnant female mouse was treated 
with tamoxifen for three days before birth by IP, immunostainings for 
epidermal markers (Keratin 14 (green), Keratin10 (red) and Loricirn (red)) 
were carried out  on the collected pups, as well as hair follicle stem cell 
marker Lhx2 (arrows show positive Lhx2 cells). Scale = 100µm. (b) 8-week-
old mice were treated with tamoxifen by IP, then depilation was carried out 
and skin collected 5 days after depilation. Arrows show staining for Keratin 
10 in the hair follicles of Tam treated mouse.   
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3.6. Global gene expression profiling of the epidermis in 
Ctcf-deficient skin 
3.6.1. Microarray analysis of gene expression in the epidermis of Ctcf 
depleted mice 
To determine the possible biological processes that underlie the 
development of epidermal phenotype (increased epidermal 
thickness/proliferation, epidermal barriers defects, inflammation) upon Ctcf 
depletion in the skin, gene expression microarray analysis was performed.  
Epidermal samples of the skin of Ctcf-deficient and control mice on 
day 7 after tamoxifen/DMSO treatment were isolated by laser capture 
microdissection (LCM) (Fig. 3.23). The RNA from the captured epidermis 
was amplified and processed for microarray profiling (Agilent platform), as 
described previously (Sharov et al., 2006, 2009; Mardaryev et al., 2014).    
The number of the RNA transcripts for the genes and long non-
coding RNAs showing two-fold or higher changes in expression between 
Ctcf-deficient  and control mice was identified to be about 15,000. These 
transcripts were manually placed into one of these categories according to 
their most appropriate function: signaling, metabolism, proteolysis, RNA 
processing, cell cycle/apoptosis, nuclear and chromatin assembly, 
cytoskeleton/differentiation, adhesion/extracellular matrix, covalent 
modification of histones and non-histone proteins, long non coding RNA, 
transcription regulation, others and unknown (Fig. 3.24). Interestingly, non- 
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coding RNAs made about 14% of over-expressed transcripts while under-
expressed consisted of 26% (Fig. 3.24).  
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Figure 3.23. Laser capture microdissection (LCM) of Ctcf-/- deficient 
and control epidermis. Epidermal samples prior to and after LCM are 
shown. Illustration only (no scale). 
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Figure 3.24. Functional annotation of over- and under-represented 
genomic transcripts in Ctcf-deficient epidermis versus the controls.  
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3.6.1. Analyses of expression of lineage-specific genes in the Type I, 
Type II Keratin Custers and the Epidermal Differentiation Complex in 
the Ctcf-deficient and control epidermis 
Terminal differentiation of keratinocytes involves the expression of 
genes in the epidermal specific genomic loci located in the Keratin Type I 
locus, Keratin Type 2 locus and the Epidermal Differentiation Complex 
(Botchkarev et al., 2012). Therefore, the genes within these loci showing 
two-fold or higher change in expression between Ctcf-deficient and control 
mice were identified in microarrays and plotted relatively to their genomic 
location (Fig. 3.25).  
According to the microarray data, the expression of Krt10 was 
increased in the Ctcf-deficient epidermis compared to controls, thus 
confirming the immunostaining results (Fig. 3.25). However, Krt14 did not 
show a difference of expression between Ctcf-deficient and control 
samples. Other keratins that were upregulated in the Keratin Type I locus 
included Krt12 and Krt13, while Krt23, Krt40 and Krt15 were downregulated 
in Ctcf-deficient mice compared to controls (Appendix A).  
Interestingly, large number of keratins within the Keratin Type II locus 
showed increased expression in Ctcf-deficient epidermis versus the controls 
including the genes located between the clusters of hair keratins and inner 
root sheath keratins (Krt6b, Krt6a and Krt5) (Fig. 25.b). 
Genes that constitute the EDC locus also showed up- and down-
regulation of their expressions between Ctcf-deficient and control mice. 
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Overexpressed genes were belonging to the S100 and SPRR gene families, 
while genes belonging to the LCE family were mostly under-expressed 
verus the controls (Fig. 3.25). Interestingly, changes in expression of the 
EDC genes upon Ctcf ablation in the epidermis were very similar to the 
changes seen in the epidermis of KtyII locus knockout mice (Kumar et al., 
2015). Together with the similarities in the epidermal phenotypes of Ctcf-
deficient and KtyII knockout mice, these data suggest that alterations in 
expression of the EDC genes can, at least in part, explain the mechanisms 
of the epidermal barrier defects observed in Ctcf-deficient mice (Fig. 
3.17.c).  
3.6.2. Analyses of expression of the genes involved in the control of 
inflammation and immune response in the epidermis of Ctcf-deficient 
mice 
Firslty, large number of genes involved in the immune response were 
upregulated in the Ctcf-deficient mice, which include the following antigens: 
Cd1d1, Cd2, Cd3d, Cd4 and Cd8 (Appendix B).  
Secondly, a large number of genes encoding distinct cytokines and 
interleukins showed higher expression in Ctcf-deficient epidermis versus the 
controls. Some of these are Il1b, Il1f5, Il10ra, Il10rb, Il6ra, as well as the 
interleukin enhancer binding factors Ilf2 and Ilf3. Furthermore, a large 
number of TNF superfamily genes showed increased expression in Ctcf-
deficient epidermis compared to controls. (Appendix B).  
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Thus, this data contributes to the previous immunofluorescence 
results indicating that the inflammatory response is taking place in the skin 
of Ctcf-deficient mice confirming that epidermal barrier defects probably 
resulted in the increased penetration of microorganisms into the skin after 
Ctcf ablation.  
3.6.3. Analyses of expression of the genes involved in the control of 
cell proliferation and apoptosis in the epidermis of Ctcf-deficient 
mice 
Substantial changes were also observed in the expression of the 
genes involved in the control of cell proliferation upon Ctcf ablation. 
Upregulated genes included Pcna, cyclin B1, cyclin D3, cyclin E1, polo-like 
kinase 1, polo-like kinase 2, polo-like kinase 3, Mybl2, Bub1b, Myc, E2F1. 
Expressions of anti-apoptotic genes such as Bcl3, Bag1, Bag2, Bag3 were 
increased, while, expression of some pro-apoptotic genes (Bax, Bok) was 
decreased in the epidermis of Ctcf-deficient mice versus the controls.  
In contrast to WT mice, Ctcf-deficient epidermis also showed marked 
change in the expression of the genes implicated in a number of cutaneous 
tumorigenesis pathways: Wnt (Wnt1, Wnt3, Wnt4, Wnt5b, Wnt6, Wnt9a, 
Wnt11), Ras/MAP kinase pathway (Nras, Traf2, Map2k, Mapk1, etc) as well 
as AP-1 transcription factor components (Fos, Jun, Atf2, Jdp2). 
Interestingly, Jdp2 was the only AP-1 component showing reduced 
expression in the epidermis of Ctcf-deficient mice compared to controls 
(Appendix C).  
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Taken together, these data demonstrate that Ctcf plays an essential 
role in the control of epidermal barrier maintenance in adult skin, and is 
involved in the control of expression not only of the keratinocyte-specific 
genes, but also of the genes controlling epidermal proliferation, immune 
response and regulation of tumorigenesis.   
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Figure 3.25. Microarray data for the over- and under- expressed genes 
in the Keratin type I/II and EDC loci of Ctcf–deficient epidermis. (a) The 
location and log2 value of genes showing a 2 or greater fold change of RNA 
transcript levels in the region of the Keratin Type I locus on chromosomes 
11 in Ctcf-deficient epidermis versus the controls. (b) The location and log2 
value of genes showing a 2 or greater fold change of RNA transcript levels 
in the region of the Keratin Type II locus on chromosomes 15 in Ctcf-
deficient epidermis versus the controls. (c) The location and log2 value of 
genes showing a 2 or greater fold change of RNA transcript levels in the 
region of the Epidermal Differentiation Complex on chromosomes 3 in Ctcf- 
deficient epidermis. Expression levels of the over- or under-expressed 
genes in Ctcf-deficient epidermis versus the controls are shown in green 
and red, respectively (See Appendix A for the list of genes and their 
expression changes). 
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Figure 3.25. For Legend See Facing Page 
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4.1. Higher-order chromatin remodeling and control of 
expression of terminal differentiation-associated genes in 
epidermal kerationcytes 
During development, the genome of multi-potent stem cells becomes 
reorganized in 3D nuclear space to establish a proper spatio-temporal 
regulation of transcription underlying execution of lineage-specific gene 
expression programs (Bickmore and van Steensel, 2013; Dekker et al., 
2013; Schoenfelder et al., 2010a; Wei et al., 2013). However, mechanisms 
coordinating transcription in lineage-specific gene loci located on different 
chromosomes during cell differentiation are poorly understood. 
The mammalian epidermis is a stratified epithelium which protects the 
body against mechanical injury, dehydration and infections (Blanpain and 
Fuchs, 2009; Koster and Roop, 2007; Watt and Huck, 2013). These 
functions rely on the maintenance of a basal stem cell compartment 
orchestrating a series of differentiation events. These result in the formation 
of the cornified envelope (CE), which together with tight junctions and 
epidermal Langerhans cells forms the protective epidermal barrier (Candi et 
al., 2005; Simpson et al., 2011). Members of the keratin (K) family of 
proteins comprise the major cytoskeleton of all epithelia and are believed to 
contribute to crucial keratinocyte functions by acting as cytoskeletal 
scaffolds undergoing protein interactions in a context- and keratin isotype-
dependent manner. Of particular importance to skin cytoarchitecture are 
keratin interactions with cornified envelope and desmosomal proteins 
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(Candi et al., 2005; Simpson et al., 2011). The cornified envelope is a 
lipoprotein structure that consists of involucrin, loricrin, filaggrin, plakin 
family members, small proline-rich proteins (SPRRs), late cornified 
envelope proteins (LCEs), and S100 protein family members which become 
sequentially cross-linked to a subset of keratins during the final stages of 
epidermal differentiation (Segre, 2006). 
Lineage-specific genes activated during the execution of the epidermal 
differentiation program are clustered in the mammalian genome into several 
loci including the KtyI and KtyII gene loci located on mouse chromosomes 
11 and 15, respectively, as well as the Epidermal Differentiation Complex 
(EDC) locus located on mouse chromosome 3 (de Guzman Strong et al., 
2010; Magin et al., 2007; Martin et al., 2004). In the epidermis, gene 
expression in KtyI/KtyII loci is regulated in a tightly coordinated manner: 
while proliferating basal keratinocytes express K5, K14 and K15, the switch 
to terminal differentiation is accompanied by the expression of K1, K2e and 
K10 in postmitotic keratinocytes (Reviewed in Fuchs, 2007). Further 
transition of post-mitotic keratinocytes from the spinous to granular 
epidermal layer is accompanied by the marked increase in expression of 
the EDC genes (loricirin, filaggrin, Sprrs, LCEs, etc.) (Fuchs, 2007). 
However, despite substantial advances in understanding of the role of 
signaling pathways that act on transcription factors and epigenetic modifiers 
to control epidermal differentiation (Reviewed in Botchkarev et al., 2012; 
Frye and Benitah, 2012; Perdigoto et al., 2014), it remains unclear how 
physically separated gene loci including the EDC and the KTyI/II are 
coordinated to result in the formation of a fully functional epidermal barrier.  
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To study the potential interactions between the distinct lineage-specific 
loci in epidermal cells, genetically-engineered mice with ablation of the 
entire Keratin type II locus located on mouse chromosome 15 were 
generated in Prof. T. Magin’s laboratory at the University of Leipzig 
(Germany). The KtyII locus ablation caused dysregulated expression of 37 
genes localized in the Epidermal Differentiation Complex (EDC) locus on 
chromosome 3, leading to severe epidermal barrier defects (Kumar et al., 
2015). 
During the epidermal morphogenesis and differentiation of multi-
potent progenitor cells residing in the basal epidermal layer, the lineage-
specific EDC locus shows marked remodelling of its higher-order chromatin 
structure and relocates away from nuclear periphery into the nuclear interior 
(Mardaryev et al., 2014). This shift in the position of the EDC is associated 
with an increase in the transcriptional activity of genes involved in the control 
of terminal keratinocyte differentiation and epidermal barrier formation 
(Mardaryev et al., 2014). The process of developmentally-regulated higher-
order chromatin remodelling in the EDC locus is regulated by p63 
transcription master regulator and includes at least two interconnected 
steps: i) the Brg1-dependent relocation of the EDC away from the nuclear 
periphery into the nuclear interior and propinquity with speckles; ii) the final, 
Satb1-mediated, arrangement of chromatin conformation within the central 
domain of the locus, which contains a large number of genes activated 
during terminal keratinocyte differentiation (Mardaryev et al., 2014). 
3D-FISH experiments performed to define whether EDC and KtyII loci 
spatially interact in keratinocytes during epidermal development revealed 
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that in WT epidermis, the KtyII locus showed significantly closer localization 
to the EDC locus and Lor gene, compared to thymocytes, in which gene 
expression in both loci is shut down. In both keratinocytes and thymocytes, 
chromosome 15 showed more central positioning in the nucleus and 
contacted the internal part of the chromosome 3, which was located more 
peripherally.  
Similarly to thymocytes and in contrast to basal epidermal 
keratinocytes of WT mice, a significant movement of the Lor gene away 
from the genes that constitute 3’ or 5’ ends of the KtyII locus was seen in 
KtyII-deficient mice. This movement was also accompanied by significant 
changes in the positioning of the Lor gene relative to the chromosomal 
territory 3 (from internal to peripheral), suggesting a marked remodeling of 
the higher-order chromatin structure in the EDC upon KtyII locus ablation. 
These data suggest that ablation of the KtyII locus result in the remodeling 
of the higher-order chromatin structure of the EDC locus and its neighboring 
regions on chromosome 3 associated with marked changes in the EDC 
gene expression.  
However, additional studies are required to fully understand the impact 
of distinct protein-coding or non-protein-coding genes that control 
interactions between the KtyII and EDC loci in differentiating epithelial cells. 
In particular, the effects of long non-coding RNAs (Kretz et al., 2012; Wang 
and Chang, 2011) and microRNAs (Yi and Fuchs, 2011), that are present 
in both loci, on gene expression in both EDC and KtyII loci need to be 
carefully dissected.  
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Also, the roles of distinct transcription factors (p63, AP1, Klf4, Arnt, 
etc.) and chromatin regulators, such as Satb1, Brg1, Ctcf, cohesin, in the 
formation and maintenance of lineage-specific gene interactomes and their 
remodelling in differentiating cells remain to be clarified. Transcription 
factors promote formation of spatial gene interactomes in different cell types 
(Schoenfelder et al., 2010b; Wei et al., 2013), and p63 transcription master 
regulator control expression of Satb1 and Brg1 in epidermal progenitor cells 
(Fessing et al., 2011; Mardaryev et al., 2014). Satb1 controls specific 
conformation of the EDC locus, as well as gene expression in both EDC and 
KtyII loci (Fessing et al., 2011), while its expression is markedly decreased 
in epidermal keratinocytes of KtyII-deficien mice.  
In addition, the impact of nuclear micro-environment of the EDC and 
KtyII loci including SC35+ speckles which are enriched in the vicinity of the 
EDC locus in basal epidermal cells (Mardaryev et al., 2014) on balancing 
gene expression in keratinocyte-specific gene loci during epidermal 
differentiation remain to be defined. Given that SC35+ speckles contain 
RNA metabolic factors and non-coding RNAs (Reviewed in Sleeman and 
Trinkle-Mulcahy, 2014), while non-coding RNA TINCR modulate gene 
expression in the EDC locus via controlling RNA stability (Kretz et al., 2013), 
speckles might serve as an important component of the nuclear 
compartment, in which  EDC and KtyII loci are clustered in differentiating 
epidermal cells. 
This data support the fundamental significance of the 3D genome 
organization for the coordination of gene expression and establishment of 
distinct phenotypic features in differentiating cells. Future advances in the 
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HiC technology should help to generate global 3D gene interaction maps for 
each cell type in the mammalian organism and to elucidate how such maps 
are established during development and altered during disease.    
Finally, the impact of enhancer-promoter interactions in the control of 
gene expression in the EDC locus including the interactions of the EDC 
gene promoters with the putative enhancers residing in the KtyII locus need 
to be carefully dissected. Enhancers are the sequence modules that are 
preferentially located in the non-coding part of the genome at various 
distances from their target genes or even at different chromosomes 
(Symmons and Spitz, 2013). In normal differentiating cells, interactions 
between the genes and their enhancers are very important for execution of 
lineage-specific gene expression programs (Symmons and Spitz, 2013). 
Key regulators of development, such as Shh or Nanog genes, show looping 
outside the chromosomal territories, possibly to interact with their enhancers 
and/or to balance their expression (Amano et al., 2009; Schneider and 
Grosschedl, 2007).  
Inter-chromosomal interactions between the enhancers and gene 
promoters are pretty well established, and there are several examples of 
eukaryotic genes located on distinct chromosomes are associating 
physically in the nucleus via interactions that may have a function in 
coordinating gene expression (for review, see Williams et al., 2010)). For 
instance, the region of the IFN-gamma gene on chromosome 10 interacts 
with the regulatory regions of the T(H)2 cytokine locus on chromosome 11 
(Spilianakis et al., 2005).  
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Following the same line of arguments, it is shown that one allele of the 
insulin-like growth factor 2 (Igf2)/H19 imprinting control region (ICR) on 
chromosome 7 co-localized with one allele of Wsb1/Nf1 on chromosome 11 
(Ling et al., 2006). Interestingly that omission of CTCF abrogated this 
association and altered Wsb1/Nf1 gene expression (Ling et al., 2006). 
These findings demonstrate that CTCF mediates an interchromosomal 
association, perhaps by directing distant DNA segments to a common 
transcription factory, and the data provide a model for long-range allele-
specific associations between gene regions on different chromosomes (Ling 
et al., 2006). 
In summary, our data support the fundamental significance of the 3D 
genome organization for the coordination of gene expression and 
establishment of distinct phenotypic features in differentiating cells. Future 
advances in the HiC technology should help to generate global 3D gene 
interaction maps for each cell type in the mammalian organism and to 
elucidate how such maps are established during development and altered 
during disease.    
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4.2. Role of Ctcf in the control of skin development and 
keratinocyte differentiation in the epidermis 
4.2.1. Involvement of Ctcf in the control of epidermal and hair follicle 
development.  
Using the chromosome conformation capture technique (3C and its 
modifications 4C, 5C, Hi-C), based on the formaldehyde-mediated cross-
linking of closely located chromatin domains, it was shown that the 
mammalian genomes are organized into Topologically Associating 
Domains (TADs) having an average size of about 1MB and defined as the 
genomic regions with higher frequency of spatial chromatin contacts within 
TADs compared to adjacent regions (Pope et al., 2014). 
In differentiating cells, spatial chromatin interactions of lineage-specific 
gene promoters with their distal regulatory elements occur both in-cis and 
in-trans within and between different TADs (Bonora et al., 2014). Enhancer-
promoter gene interactomes provide functional and structural frameworks 
for lineage-specific transcription, which is controlled at several levels 
including pioneer transcription factors and chromatin architectural proteins 
(CTCF, cohesin, condensin, Satb1). 
Chromatin architectural protein CTCF controls the establishment and 
maintenance of the long-range enhancer/promoter regulatory networks in 
differentiating cells. CTCF binding sites are enriched at the borders between 
distinct TADs, where CTCF together with other chromatin architectural 
proteins is involved in demarcating distinct TADs (Ong and Corces, 2014).  
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Depletion of CTCF results in the reduction of intra-TAD interactions and 
increase of the contacts between different TADs (Zuin et al., 2014). 
Importantly, CTCF DNA binding sites are asymmetrical and most CTCF-
mediated chromatin contacts occur between the sites in convergent 
orientation (ENCODE, 2012; Rao et al., 2014). The inversion of the CTCF 
binding sites at the TAD boarders lead to rewiring of the chromatin contacts 
and changes of gene transcription in the neighboring genomic regions (Guo 
et al., 2015). CTCF binding sites also exist within TADs, in which CTCF is 
involved in organizing the smaller-sized (100-200 kb) intra-TAD chromatin 
loops and in mediating the enhancer-promoter contacts (Cubenas-Potts 
and Corces, 2015; Rao et al., 2014).  
Here, the role of CTCF in the control of skin development and postnatal 
homeostasis was explored. Our data reveal that Ctcf protein is expressed 
in both epithelial and mesenchymal compartments of the developing and 
postnatal mouse skin (Fig. 3.11, 3,12). In particular, CTCF protein is 
expressed in all layers of the epidermis, hair follicles (placodes, outher root 
sheath, hair matrix, dermal papilla), as well as in dermal cells (Fig. 3.11, 
3.12).  
Because Ctcf knockout mice die during early embryonic development 
(Moore et al., 2012), we addressed the role of Ctcf in the control of 
epidermal and hair follicle development by generating Krt14-CreER/Ctcf fl/fl 
mice with tamoxifen-induced Ctcf ablation in Keratin 14-expressing basal 
epidermal and outer root sheath keratinocytes. Ctcf fl/fl mice were obtained 
from N. Glajart (Erasmus Medical Center, Rotterdam, Netherlands). 
Tamoxifen (TAM) was injected into Krt14-CreER/Ctcf fl/fl pregnant females 
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between E12.5-14.5, and Ctcf ablation was confirmed by lack of Ctcf protein 
in the isolated epidermis (Fig. 3.10). 
 Skin of TAM-treated embryos (E16.5-E18.5) showed marked increase 
of the epidermal thickness and proliferation, as well as the retardation of 
their development (Fig. 3.10, 3.11). Also, epidermis of E16.5 TAM-treated 
Krt14-CreER/Ctcf fl/fl mice showed marked expansion of Keratin 14 into 
suprabasal layers, increased Keratin 10 expression, while Loricirn 
expression was unchanged compared to controls (Fig. 3.12). These data 
allowed concluding that Ctcf indeed plays an essential role in the control of 
execution of lineage-specific differentiation programmes in skin epithelial 
cells during development, most likely, via global regulation of the higher-
order chromatin folding and control of the enhancer-promoter interactions. 
4.2.2. Invovlement of Ctcf in the control of epidermal homeostasis 
and barrier maintenance in adult mice.  
  To address the role of Ctcf in the maintenance of homeostasis in 
adult epidermis, TAM was injected into 8 week-old Krt14-CreER/Ctcf fl/fl 
mice, as well was topically applied onto the skin. Ctcf ablation in adult 
epidermis resulted in marked changes in the epidermal integrity 
accompanied by increase of the epidermal thickness and proliferation 
followed by alterations in the epidermal barrier maintenance (Fig. 3.17, 
3.18). These changes were accompanied by the alterations in expression 
of the epidermal keratins (Krt14, Krt10) and expansion of the Krt10 
expression into the hair follicle infundibulum (Fig. 3.19). 
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Microarray analyses of the epidermal samples isolated from Krt14-
CreER/Ctcf fl/fl mice reveal marked alterations in expression of the 
keratinocyte-specific genes that constitute the EDC, KtyI and KtyII loci upon 
Ctcf ablation (Fig. 3.20). Interestingly, the profile of changes in expression 
of the EDC genes including downregulation of the Loricrin, Lce family genes 
and upregulation of the Sprr family genes strikingly resemble changes in 
expression of the EDC genes seen in the KtyII locus knock-out mice (Kumar 
et al., 2015). 
Furthermore, our 3D FISH analyses show that EDC locus in Ctcf-
deficient mice moved away from the KtyII locus and relocate towards 
nuclear periphery (Fig. 3.20). Similar changes in the positioning of the EDC 
locus were observed in KtyII locus knock-out mice (Fig. 3.7), suggesting 
that Ctcf might be involved in the regulation of the cross-talk between the 
EDC and KtyII loci in epidermal cells during the execution of terminal 
differentiation programme. These data are quite consistent with previous 
reports demonstrating that CTCF controls the establishment of inter-
chromosomal associations between the insulin-like growth factor 2 
(Igf2)/H19 imprinting control region (ICR) on chromosome 7 and Wsb1/Nf1 
gene on chromosome 11, while Ctcf ablation result in altered Wsb1/Nf1 
gene expression (Ling et al., 2006).             
  Alterations in epidermal barrier formation upon Ctcf ablation was also 
accompanied by appearance of the Cd4 and Cd8 cells in the epidermis and 
development of the epidermal inflammatory response (Fig. 3.21), possibly, 
due to the influx of bacteria into the epidermis (Bognar et al., 2014; Darido 
et al., 2016). Microarray data obtained from the epidermis of Krt14-
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CreER/Ctcf fl/fl mice show marked alterations in expression of numerous 
genes mediating inflammatory response, including cytokines (Il1b, Il1f5, 
Il10ra, Il10rb, Il6ra), adhesion molecules and membrane receptors 
(Appendix B). However, additional experiments are required to fully 
understand whether expression of these genes is under direct control of Ctcf 
or changes in their expression occur as a result of epidermal inflammation 
occurring after alterations of epidermal barrier integrity upon Ctcf ablation. 
The same is true for the genes encoding the components of cell cycle-
associated machinery and controlling keratinocyte proliferation (Pcna, 
cyclin B1, cyclin D3, cyclin E1, polo-like kinase 1, polo-like kinase 2, polo-
like kinase 3, Mybl2, Bub1b, Myc, E2F1), as well for the genes encoding the 
distinct signaling molecules and transcription factors relevant to the 
regulation of epidermal homeostasis (Wnt pathway, RAS/MAPK pathway, 
TNF pathway) (Appendix B, C). Additional ChIPseq analyses are required 
to prove direct binding of Ctcf to the promoters of those genes and/or to the 
putative distal regulatory/enhancer elements that might control their 
expression.    
  These analyses will provide an important platform for obtaining 
novel fundamental information on how Ctcf regulates the establishment of 
enhancer-promoter regulatory networks in distinct epithelial cell populations 
in the skin during development, postnatal regeneration and response to 
different environmental stressors. In global context, these data will provide 
an important foundation for further studies on how enhancer-promoter 
networks of active or repressed genes and their enhancers are changed in 
the disorders associated with alterations of epidermal differentiation 
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(psoriasis) or in epidermal tumors, and how development of these disorders 
can be managed via targeting distinct chromatin remodeling factors and 
modulating enhancer-promoter interactions. 
Interestingly, preliminary data shows that upon Ctcf-depletion 
because of tamoxifen treatment of K14-CreER/Ctcf-floxed mice the cells of 
the hair follicles start expressing epidermal specific genes such as Keratin 
10 and Loricrin (Fig. 2.23). This suggests that Ctcf is important for the 
maintenance of skin appendages during normal homeostasis. Recently, it 
has been shown that during aging hair follicle stem cells acquire epidermal 
fate leading to the loss of the hair follicle (Matsumura et al., 2016). Due to 
striking similarities in phenotype it would be interesting to determine if 
expression of Ctcf might play a role in aging of the hair follicles.         
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5. CONCLUSIONS 
Based on the generated data in this thesis the following conclusions can be 
made: 
 
1) The organisation of the nucleus in keratinocytes is tissue-specific 
with genomic loci containing genes which are responsible for 
epidermal development being arranged in a non-random manner. 
This is evident by closer topological association detected between 
Epidermal Differentiation Complex (EDC) located on mouse 
chromosome 3 and Keratin Type II (KtyII) locus on chromosome 11 
in keratinocytes, while in thymocytes the distances between these 
loci are significantly larger.  
2) Genetic ablation of KtyII locus results in relocation of the EDC locus 
away from the nuclear compartment containing the flanking regions 
of the KtyII locus and enriched by nuclear speckles:  the distances 
between the EDC and the flanking regions of KtyII locus are 
significantly increased, while the positioning of Loricrin gene within 
the chromosome territory 3 changes to a more peripheral location in 
KtyII deficient epidermal nuclei. These data demonstrate topological 
and possibly functional relationships between the EDC and KtyII loci, 
which also include nuclear speckles, likely providing the environment 
facilitating coordinated gene expression in the EDC and KtyII loci.  
3) The chromatin architectural protein Ctcf is essential for proper control 
of epidermal and hair follicle development. It is expressed in all cells 
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of the skin including the epidermis, dermis and hair follicle. Condition 
ablation of Ctcf in developing embryos under the control of Keratin 
14 promoter results in the increased keratinocyte proliferation and 
epidermal thickness, alterations in expression of the epidermal 
differentiation associated genes, and in retardation of hair follicle 
development.  
4) Keratin 14-driven Ctcf ablation in adult skin also results in increase 
of the epidermal proliferation and thickness, alterations in expression 
of epidermal keratins (Krt14, Krt10), as well as in perturbation of 
epidermal barrier integrity accompanied by infiltration of the immune 
cells and development of inflammatory skin response. 3D FISH 
analysis of the EDC and KtyII locus showed that similarly to KtyII 
locus knock-out mice, Ctcf ablation in the epidermis results in results 
in relocation of the EDC locus away from the KtyII locus, thus 
suggesting Ctcf involvement in the control of topological associations 
between both loci and possible functional cross-talk between them.  
5) The microarray analysis of Ctcf-deficient epidermis revealed that the 
expression of approximately 15000 genes was affected. Many of the 
genes, which expression is altered upon Ctcf ablation are involved in 
the control of cell proliferation, keratinocyte differentiation, immune 
response, as well as controlling the activities of Wnt and Ras/MAP 
signalling pathways. Changes in the expression profile of 
keratinocyte-specific genes located in the EDC locus closely match 
the profile of changes in expression of the EDC genes seen in the 
epidermis of KtyII locus published previously, which suggest a role 
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for Ctcf in the control of functional relationships and possibly 
enhancer-promoter interactions between two loci during epidermal 
development and keratinocyte differentiation. 
 
Taken together, the data presented in this Thesis, demonstrate that Ctcf-
mediated chromatin assembly serve as crucial mechanism which enables 
the coordinated gene expression and inter-chromosomal interactions 
between lineage-specific gene loci in epidermal keratinocytes during skin 
development and postnatal homeostasis, while perturbation of this 
mechanism result in alterations of the epidermal barrier integrity and leads 
to skin inflammation.     
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6. FUTURE DIRECTIONS OF RESEARCH 
At this moment, many aspects of the biology of keratinocyte nucleus and 
epigenetic control of gene expression are still unclear and at least several 
important issues need to be resolved: 
1) Because enhancer-promoter interactions play a fundamental role in the 
control of gene expression in differentiating cells (Bock et al., 2012), I will 
assess a potential impact of the functional enhancers in the KtyII locus that 
might be involved in coordinating the expression of lineage-specific genes in 
the EDC locus during keratinocyte differentiation; 
2) Because Ctcf-deficient mice show remarkable changes in the 
expression of genes located in the EDC locus, I will use 3D-FISH to determine 
the conformational changes that occur in the different compartments of this 
locus and correlate these data with the data chromosome conformation capture 
(5C) analyses recently obtained in our laboratory.  
3) The thickness of the epidermis in Ctcf-deficient mice is increased 
compared to controls. Furthermore, there was evidence that some DAPI 
positive cells were detected to be present above the cornified epidermal layer 
in Ctcf-deficient mice. This indicates that some keratinocytes have failed to 
acquire a cornified fate and might be at the initiat stages of tumour formation. 
Therefore, I will further investigate this phenomenon.  
4) Hair follicle cycling is likely to be affected as the result of Ctcf ablation 
because Ctcf is expressed strongly in the hair follicles in WT mice. Therefore, I 
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will induce hair cycling to investigate further the phenotype of the hair follicles 
and details of their cyclic activities upon Ctcf deficiency.  
  Because advances of pharmacogenomics resulted in the development of 
a number of molecules that are capable of modulating distinct epigenetic regulatory 
mechanisms, the research in this direction will help to bridge the gap between our 
current knowledge of basic epigenetic mechanisms and potential applications of 
epigenetic modulators for treatment on many dermatological disorders including 
epidermal cancers and psoriasis, as well as for protection of skin against 
environmental stressors and aging.   
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Appendix A 
Microarray -> Up- and Down- regulated genes located in the 
KtyI, KtyII and EDC loci in Ctcf-deficient epidermis 
Location Systematic Name Gene Name 
Fold 
Change 
(KO vs 
WT) 
    
KtyI  
(Ch11) 
NM_172946 Krt222 5.68 
NM_010660 Krt10 55.04 
NM_010661 Krt12 15.84 
NM_033373 Krt23 -28.95 
NM_001039666 Krt40 -2.11 
NM_025524 Krtap3-3 -10.56 
NM_025720 Krtap3-2 -2.92 
NM_001039502 Krtap1-4 2.88 
NM_001048196 Krtap4-1 -7.67 
NM_001126322 Gm11595 -2.32 
NM_001126322 Gm11595 7.24 
NM_001195383 2300003K06Rik 2.26 
NM_001177484 Gm11559 3.02 
NM_015741 Krtap9-1 2.71 
NM_013570 Krt33b 2.51 
chr11:99970341-
99973420_R 
chr11:99970341-
99973420_R -6.91 
NM_010662 Krt13 43.33 
NM_008469 Krt15 -3.03 
    
KtyII (5' 
Flank) 
ENSMUST00000000544 Acvr1b 38.08 
NM_019518 Grasp 14.44 
chr15:101084597-
101095097_R 
chr15:101084597-
101095097_R -2.15 
chr15:101084597-
101095097_F 
chr15:101084597-
101095097_F -9.46 
NM_010444 Nr4a1 -10.07 
NM_026566 Atg101 5.51 
NR_033803 6030408B16Rik -3.49 
KtyII 
(Ch15) 
NM_028770 Krt80 2.24 
NM_016879 Krt85 2.13 
NR_002868 Gm5476 1,679.67 
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NR_003960 Gm5478 2,439.65 
NM_010669 Krt6b 507,338.01 
NM_008476 Krt6a 5,179.94 
NM_027011 Krt5 15.69 
NR_033444 Krt74 2.96 
NM_212485 Krt73 3.79 
NM_010668 Krt2 -7.42 
NM_008473 Krt1 14.74 
NM_146063 Krt79 7,398.07 
NM_212487 Krt78 4.32 
KtyII 
(3'Flank) 
TC1699452 TC1699452 2.01 
NM_145625 Eif4b 2.96 
NM_001033277 Spryd3 -2.42 
NM_008344 Igfbp6 -6.66 
    
EDC 
(5'Flank) 
NM_001253738 Tpm3 4.18 
NM_206924 Jtb 2.14 
NM_145540 Ints3 31.09 
NM_133854 Snapin 44.14 
NM_026374 Ilf2 35.02 
NM_023215 Chtop -5.63 
EDC 
(Ch3) 
NM_025393 S100a14 8.54 
NM_026416 S100a16 29.26 
NM_011310 S100a3 3.83 
NM_011311 S100a4 -2.13 
NM_011313 S100a6 5.99 
chr3:90427029-
90427674_F 
chr3:90427029-
90427674_F -5.71 
chr3:90425270-
90435820_F 
chr3:90425270-
90435820_F -2.39 
chr3:90425270-
90435820_R 
chr3:90425270-
90435820_R -6.52 
NM_013650 S100a8 2,223.64 
NM_001281852 S100a9 34,360.85 
XM_619923 Gm5849 -242.36 
NM_207247 Pglyrp3 8.42 
NM_008508 Lor -48.42 
NM_175424 Prr9 32.02 
NM_001164787 Sprr2a2 44.17 
chr3:92065425-
92086850_F 
chr3:92065425-
92086850_F 11.27 
NM_011469 Sprr2b 4.00 
NM_011470 Sprr2d 40,390.23 
NM_011471 Sprr2e 2,460.87 
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NM_011472 Sprr2f 687.50 
NR_003548 Sprr2g 345.66 
NM_011474 Sprr2h 3,208.59 
NM_011475 Sprr2i 292.46 
NR_003185 Sprr2j-ps 210.57 
NM_011477 Sprr2k 157.39 
NM_009265 Sprr1b 46,799.92 
NM_009264 Sprr1a 8.04 
XM_006502579 2310046K23Rik 10.56 
NM_008412 Ivl 3.68 
AK131883 2210017I01Rik -24.79 
NM_025984 Lce1a1 -9.22 
NM_026822 Lce1b -113.56 
NM_028625 Lce1a2 -35.35 
NM_028622 Lce1c -18.46 
NM_027137 Lce1d -52.18 
NM_026811 Lce1e -22.78 
NM_026394 Lce1f -4.94 
NM_025413 Lce1g -10.87 
NM_026335 Lce1h -18.14 
NM_029667 Lce1i -25.73 
NM_001254760 Lce1k -2.72 
NM_028629 Kprp -5.00 
NM_028628 Lce1l -2,538.81 
NM_025621 2310050C09Rik -6.89 
NM_001039594 Lce3a 4,476.79 
NM_025501 Lce3b 1,980.18 
NM_033175 Lce3c 1,947.31 
NM_001270426 Lce3d 1,836.91 
NM_001254725 Lce3e 71.06 
NM_001018079 Lce3f 38.32 
NM_028798 Crct1 -4.65 
NM_025420 Lce1m -123.44 
NM_001177694 Gm4858 17.16 
XM_006502513 Flg 96.71 
chr3:93150619-
93184368_F 
chr3:93150619-
93184368_F -7.96 
chr3:93156491-
93157100_R 
chr3:93156491-
93157100_R 2.39 
chr3:93162669-
93163114_R 
chr3:93162669-
93163114_R 1,436.73 
NM_001163098 Tchh 10.29 
NM_027762 Tchhl1 247.22 
NM_016740 S100a11 13.94 
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EDC 
(3'Flank) 
chr3:93564825-
93576725_F 
chr3:93564825-
93576725_F 6.50 
chr3:93564825-
93576725_R 
chr3:93564825-
93576725_R 27.59 
chr3:93582250-
93592950_R 
chr3:93582250-
93592950_R -3.94 
chr3:93582250-
93592950_F 
chr3:93582250-
93592950_F 2.83 
NM_207272 Tdpoz4 3.67 
NM_025416 Them5 12.59 
NM_011281 Rorc -82.07 
NM_030116 Mrpl9 5.04 
NM_172434 Celf3 -11.71 
NM_001082484 Snx27 8.75 
NM_011656 Tuft1 -2.78 
NR_033629 BC021767 -2.97 
NM_001037711 Cgn -3.40 
NM_172683 Pogz -10.13 
NM_008945 Psmb4 3.34 
NM_009150 Selenbp1 2.05 
AK080218 AK080218 8.10 
NM_175356 Pi4kb 14.37 
XR_104791 4930481B07Rik 3.29 
NM_001282017 Psmd4 4.89 
ENSMUST00000107229 Pip5k1a 13.50 
NM_027013 Scnm1 -2.17 
NM_153121 Lysmd1 -2.78 
NM_027206 Tnfaip8l2 6.94 
NM_001272024 Sema6c -9.51 
NM_019914 Mllt11 8.41 
NM_172395 Cdc42se1 -9.75 
NM_173347 Prune -2.16 
NM_001163641 Setdb1 6.53 
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Appendix B 
Up- and Down- regulated genes encoding markers of 
inflammation in Ctcf-deficient epidermis 
Description Systematic Name 
Gene 
Name Fold change 
Chemockine
s 
NM_021274 Cxcl10 63.57293 
NM_023158 Cxcl16 10.20384 
NM_009987 Cx3cr1 43.03822 
NM_011331 Ccl12 14.17923 
NM_011332 Ccl17 8.23584 
NM_011888 Ccl19 5.285617 
NM_019577 Ccl24 10.21593 
ENSMUST00000127258 Ccl25 71.82595 
NM_013652 Ccl4 3.407974 
NM_013653 Ccl5 10.52655 
NM_009139 Ccl6 46.59656 
NM_021443 Ccl8 441.0218 
NM_011338 Ccl9 2.367918 
Chemokine 
receptors 
NM_009835 Ccr6 6.749127 
NM_009913 Ccr9 15.42049 
Interleukins 
NM_008355 Il13 8.009829 
NM_019508 Il17b 6.869407 
NM_145856 Il17f 8.174024 
NM_001009940 Il19 369.1288 
NM_145636 Il27 6.591907 
NM_008361 Il1b 24.48801 
NM_001164724 Il33 3.331655 
NM_153077 Il1f10 2.487037 
NM_001146087 Il1f5 3.997181 
ENSMUST00000028360 Il1f5 13.91479 
NM_019450 Il1f6 144.8322 
NM_021380 Il20 3.059243 
NM_026374 Ilf2 35.0206 
NM_001042708 Ilf3 4.866282 
Interleukin 
receptors 
NM_010555 Il1r2 26.66779 
NM_134159 Il17rc 25.99578 
NM_001034031 Il17re 70.46397 
NM_008348 Il10ra 13.14939 
NM_008349 Il10rb 2.224618 
NM_008353 Il12rb1 16.04996 
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ENSMUST00000122880 Il20rb 2.586905 
NM_021887 Il21r 25.15845 
NM_178257 Il22ra1 2.501165 
NM_001008700 Il4ra 393.8084 
NM_010559 Il6ra 2.407837 
NM_008372 Il7r 7.531985 
NM_172161 Irak2 2.625167 
NM_029926 Irak4 17.3532 
Interferons 
NM_008390 Irf1 13.17332 
NM_001164598 Irf2bp2 6.757885 
NM_016849 Irf3 2.246504 
NM_012057 Irf5 22.88487 
NM_016851 Irf6 26.39216 
NM_016850 Irf7 4.988583 
NM_008320 Irf8 4.32837 
NM_001159417 Irf9 9.526632 
NM_008327 Ifi202b 7.068321 
NM_023065 Ifi30 5.798691 
NM_001271676 Ifi47 25.44117 
NM_027835 Ifih1 63.64412 
NM_008331 Ifit1 31.65316 
NM_010501 Ifit3 44.36186 
BC090258 Ifitm1 167.5821 
NM_001112715 Ifitm1 161.1279 
NM_030694 Ifitm2 2.042918 
NM_025378 Ifitm3 2.708868 
NM_008336 Ifnab 2.100527 
NM_010508 Ifnar1 55.14115 
NM_008338 Ifngr2 7.212033 
NM_177396 Ifnl3 2.508403 
NM_008338 Ifngr2 7.212033 
Antigens 
NM_027353 Cd2bp2 5.112248 
NM_013488 Cd4 6.88262 
NM_007639 Cd1d1 4.930678 
NM_013486 Cd2 6.035227 
NM_013487 Cd3d 90.69718 
NM_009858 Cd8b1 7.670959 
Tumor 
Necrosis 
Factor and 
functionaly 
related 
proteins 
NM_009395 Tnfaip1 3.51937 
NM_025566 Tnfaip8l1 3.362026 
NM_027206 Tnfaip8l2 6.94304 
NM_001033535 Tnfaip8l3 2.625648 
NM_020275 Tnfrsf10b 20.1257 
NM_009399 Tnfrsf11a 3.97871 
NM_013749 Tnfrsf12a 6.655565 
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NM_021349 Tnfrsf13b 6.38663 
ENSMUST00000010286 Tnfrsf13b 3.617712 
NM_178931 Tnfrsf14 2.425671 
NM_011609 Tnfrsf1a 7.985707 
NM_011610 Tnfrsf1b 6.093975 
NM_023680 Tnfrsf22 24.20216 
NM_001291010 Tnfrsf25 13.34663 
NM_011659 Tnfrsf4 53.34445 
NM_009425 Tnfsf10 12.6998 
NM_011614 Tnfsf12 6.552348 
NM_001204129 C1qtnf1 11.87677 
NM_026161 C1qtnf4 7.003693 
NM_001135172 C1qtnf7 4.386667 
NM_013693 Tnf -8.02892 
NM_009396 Tnfaip2 -2.90673 
NM_009396 Tnfaip2 -3.5474 
NM_009397 Tnfaip3 -3.83439 
ENSMUST00000087655 Tnfaip8 -2.99536 
NM_134131 Tnfaip8 -2.23739 
NM_178931 Tnfrsf14 -2.4443 
NM_011614 Tnfsf12 -2.88131 
NM_019418 Tnfsf14 -2.31766 
NM_177371 Tnfsf15 -3.0118 
NM_009452 Tnfsf4 -3.78697 
NM_009404 Tnfsf9 -2.20012 
NM_030888 C1qtnf3 -2.14174 
NM_001040632 C1qtnf5 -4.82601 
NM_001290413 Traf2 3.826462 
NM_009423 Traf4 38.30579 
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Appendix C 
Microarray -> Up- and Down- regulated genes 
encoding the components of the Wnt, Ras/MAPK 
pathways and genes associated with cell 
proliferation in Ctcf-deficient epidermis 
Description  Systematic Name Gene Name Fold change 
Wnts 
NM_021279 Wnt1 2.109472 
NM_009519 Wnt11 3.192289 
NM_009521 Wnt3 49.18276 
NM_009523 Wnt4 34.91845 
NM_001271757 Wnt5b 38.16997 
NM_009526 Wnt6 5.384671 
NM_139298 Wnt9a 4.290247 
Frizzled 
NM_021457 Fzd1 2.471462 
NM_175284 Fzd10 5.14803 
NM_020510 Fzd2 7.488425 
Catenins 
NM_009818 Ctnna1 12.02814 
NM_018761 Ctnnal1 24.69156 
NM_007614 Ctnnb1 2.787573 
NM_008729 Ctnnd2 933.6963 
Mitogen-
activated 
protein 
kinases 
NM_023138 Map2k2 7.215186 
NM_008928 Map2k3 4.217574 
NM_011840 Map2k5 29.22494 
NM_022012 Map3k11 24.17372 
NM_172688 Map3k7 2.780265 
NM_009316 Map3k7 5.379415 
NM_009316 Map3k7 3.585435 
NM_001174107 Map3k9 158.3603 
NM_008279 Map4k1 3.386788 
NM_001252200 Map4k4 14.36766 
NM_011949 Mapk1 3.498964 
NM_011161 Mapk11 5.878304 
NM_011950 Mapk13 3.270181 
NM_001045483 Mapk1ip1 2.419902 
NM_178684 Mapk1ip1l 85.00155 
NM_011952 Mapk3 2.465029 
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NM_027418 Mapk6 2.76048 
NM_027418 Mapk6 12.21834 
NM_001291035 Mapk7 2.069683 
NM_001163672 Mapk9 4.845601 
NM_177345 Mapkap1 14.22787 
Ras oncogene 
family 
NM_010937 Nras 41.95171 
NM_008996 Rab1 2.854228 
NM_016676 Rab10 32.20608 
NM_017382 Rab11a 20.04682 
NM_008997 Rab11b 2.06843 
NM_001162869 Rab11fip3 4.917655 
NM_011227 Rab20 2.055453 
NM_024436 Rab22a 12.15765 
NM_009000 Rab24 2.779097 
NM_016899 Rab25 47.73537 
NM_030554 Rab27b 29.86136 
NM_021518 Rab2a 3.56543 
NM_029494 Rab30 2.566998 
NM_033475 Rab34 5.028245 
NM_028238 Rab38 5.990247 
NM_001003950 Rab3ip 3.98232 
NM_139147 Rab40b 7.426587 
NM_001039394 Rab43 12.46993 
NM_025887 Rab5a 10.28514 
NM_177411 Rab5b 2.572581 
NM_024456 Rab5c 3.959347 
NM_023126 Rab8a 19.94941 
NM_023126 Rab8a 3.077203 
NM_019773 Rab9 4.682927 
NM_001042499 Rabl3 4.952166 
NM_001042499 Rabl3 3.770869 
NM_001042499 Rabl3 3.618579 
NM_001042499 Rabl3 3.550022 
NM_001042499 Rabl3 3.230798 
NM_001042499 Rabl3 3.155877 
NM_001042499 Rabl3 2.655396 
NM_001042499 Rabl3 2.368025 
NM_009391 Ran 4.025635 
AP-1 
transcription 
factor 
NM_010591 Jun 6.554234 
NM_010234 Fos 4.166305 
NM_001025093 Atf2 10.33356 
NM_030693 Atf5 2.972092 
NM_030887 Jdp2 -2.97483 
NM_011045 Pcna 4.753593 
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Cell 
Proliferation 
NM_007628 Ccna1 3.263863 
NM_009828 Ccna2 21.72714 
NM_172301 Ccnb1 11.53468 
NM_007630 Ccnb2 12.55595 
NM_001290422 Ccnc 3.6006 
NM_001081636 Ccnd3 2.842782 
NM_007633 Ccne1 50.0847 
NM_007634 Ccnf 6.158865 
NM_207678 Ccnl2 3.113778 
NM_026484 Ccny 2.512979 
NM_011121 Plk1 5.147278 
NM_152804 Plk2 5.142394 
NM_013807 Plk3 36.68944 
NM_008652 Mybl2 22.53564 
NM_010849 Myc 4.675824 
NM_009773 Bub1b 14.53972 
NM_009774 Bub3 3.732622 
NM_007891 E2f1 4.709477 
NM_033270 E2f6 14.82271 
NM_178609 E2f7 12.36322 
NM_001013368 E2f8 12.47226 
NM_033601 Bcl3 14.33041 
NM_001171739 Bag1 2.860185 
NM_013863 Bag3 5.820841 
NM_007527 Bax -8.98582 
NM_016778 Bok -5.2024 
NM_177410 Bcl2 -17.7539 
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